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Abstract
The Framingham Risk Score (FRS) was developed to determine the likelihood of

developing cardiovascular disease (CVD) in the next 10 years using an individual’s age,

gender, total cholesterol (TC), High Density Lipoprotein Cholesterol (HDL-C), smoking

habits, and systolic blood pressure (SBP). Run-Sprint Interval Training (R-SIT) has shown
improvements in various health and blood markers while reducing total exercise time. To

date there has not been a study that examines the effects of R-SIT and Moderate Intensity
Training (MIT) on Framingham Risk. The purpose of this study was to determine if a

reduction of the 10-year risk of CVD (determined by Framingham CVD risk calculator), is
greater in an R-SIT experimental group compared to a moderate intensity group (MIT) of
sedentary prediabetic women, after a 16-week intervention. Participants were randomized

into R-SIT (n=6) or MIT (n=9) groups and required to attend 3 weekly training sessions and
1 weekly Diabetes Prevention Program session for 16-weeks. During the first 4 weeks, RSIT performed 4x30s maximal sprints on a treadmill at a self-selected speed and incline,
followed by a 4-min active recovery between intervals. Intervals increased by 2 every 4

weeks. MIT walked continuously at 45-55% Heart Rate Reserve for 30-mins during the first
4 weeks, and increased by 10-mins every 4 weeks. FRS markers were measured at baseline,
mid, and post intervention.

After 16-weeks of exercise training, there was a significant time by group interaction

in weight, Body Mass Index (BMI), and Body Fat Percent (BF%). T-tests indicate MIT
significantly decreased in weight (-2.60+1.32 kg), BF% (-1.58+1.54), and BMI

(-2.42+1.32 kg). R-SIT significantly changed in BF% from baseline to mid (-2.33+0.72) and
mid to post (+1.53+0.46), but not from baseline to post (-2.16+2.53). Additionally, there
was a trend toward significant improvements in BMI (p=0.078) and lean body mass
vi

(p=0.059) (-0.85+0.06 kg/m2, +1.05+0.46 kg, respectively). Lastly, R-SIT participants also

significantly decreased changes in TGs from midline to post (-23.33+17.92 mg/dL). Though
FRS and Vascular Age (VA) were significantly different between groups at all three time
points, there were no significant within group changes observed

The major findings of this study were that after 16-weeks of exercise training, MIT

had significant within group decreases for weight, BMI, and BF%, while R-SIT significantly
decreased in BF% and VO2max (mLkg-1min-1). In conclusion, though previous R-SIT and

HIIT studies have suggested improved body composition and cardiovascular risk factors
when compared to MIT, the present study only observed significant changes in body

composition and minimal changes to CVD risk factors. Additional research is needed to
further understand the effects of R-SIT on blood lipid profiles and its relationship with
CVD, especially in the clinical population.
Keywords

Framingham Heart Study; Cardiovascular Disease (CVD); High Intensity Interval Training
(HIIT); exercise intensity; interval training; diabetes
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1
Introduction

Chapter I

According to the Centers for Disease Control and Prevention (CDC), more than one

third of the American adult population are obese (1). Often there is a correlation between

obesity and sedentary behavior (2, 3). Consequently, obesity and inactivity are known to be
linked to health related problems such as cardiovascular disease (CVD), stroke, insulin
resistance, type 2 diabetes, certain types of cancer, reproductive abnormalities, and

osteoarthritis (2-8). According to Reaven et al., both obesity and sedentary behaviors are

“strongly and independently” associated with diabetes and its comorbidities (3). As a result
of this link between inactivity and certain diseases, emerging research exploring the role of
exercise is being closely investigated. Exercise is a direct, cost-effective way of improving

overall health (5-7, 9, 10). Improved fitness has proven benefits to cardiovascular health and
the prevention of metabolic diseases such as CVD and type 2 diabetes (2, 3, 11-15).

Furthermore, it can also “reverse” some of the adverse effects associated with metabolic

syndrome (16). According to Bird et al., there is “no single intervention with greater efficacy
than physical exercise to reduce the risk of virtually all chronic diseases simultaneously” (17).
Benefits of exercise training include reduced blood pressure (BP), increased high-density
lipoprotein cholesterol (HDL-C), improved body composition, and improved VO 2max.

The American College of Sports Medicine (ACSM) recommends that most adults

should accumulate at least 150 minutes a week of moderate intensity, 75 minutes per week of
vigorous intensity, or a daily combination of moderate and vigorous aerobic exercise per

week (18). Individuals participating in these recommendations have shown improvements in
fasting blood glucose and type 2 diabetes risk (19). For diabetics there may be additional
benefits gained from intensities >60% of VO 2max (19). According to a meta-analysis
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conducted by Boule et al., when compared to moderate intensity exercise, higher intensities
produced better results in glucose control and VO 2max in type 2 diabetics (20).

Despite exercise being a cost-efficient and effective response to many of the acute

and chronic diseases that Americans face, only about 15% of American adults participate in
vigorous regular exercise (three times a week for at least 20 minutes) and only 22%

participate in regular exercise at any intensity (five times a week for at least 30 minutes) (21).
The most-cited reason for poor participation in exercise programs, regardless of age, sex,

ethnic background, or health status (17), is a lack of time (7, 9, 13, 22-24). For many, time is
limited and ACSM’s recommendations seem unrealistic and unattainable (17). As a result,

more research has focused on reducing the time factor involved in physical activity, while

maintaining and/or improving aerobic and metabolic benefits seen with traditional exercise
programs (7, 9, 13, 22-24).

High intensity interval training (HIIT) is an exercise protocol that has recently been

the subject of many research studies (2, 5, 7-10, 16, 22, 25-37). HIIT is defined as intense

periods of intermittent exercise above anaerobic threshold (80-100% maximal heart rate or
%HRmax), separated by periods of rest or low intensity exercise that do not allow for full
recovery (10, 38, 39). Repeated bouts at a high intensity have shown improved lipid

oxidation, insulin sensitivity, and vascular endothelial function as well as increased maximal

oxygen uptake and decreased subcutaneous fat (2, 17). The observed benefits are thought to
be the result of continuous stress that increases participants’ metabolic demand, more so

than traditional endurance exercise (2). Not only has HIIT proven to produce rapid aerobic

improvements similar to what is seen in traditional endurance protocols, but it accomplishes
this in less active time (7, 13, 17, 23).
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HIIT encompasses several different exercise interventions that manipulate levels of

intensity, interval duration, recovery times, and total work volume (10, 38). Additionally, it

encompasses various modalities, including running and cycle ergometers. Generally, HIIT

protocols are completed at near maximal intensities (between 80-100%) for longer periods of
time (three-four minutes) (39). Sprint Interval Training (SIT), a type of HIIT, incorporates

all-out supramaximal (>100% %HRmax) all-out sprint intervals (~30 seconds) with relatively
long periods of active recovery between the intervals (39). The major difference between
HIIT and SIT is in the ‘all-out’ effort expected of the participants. The higher intensity

results in shorter intervals and total duration (10, 37, 38). Generally, HIIT protocols are
completed at high (but not maximal) intensities for longer periods of time (two-four

minutes) (38). Both HIIT and SIT have shown rapid, beneficial adaptations that may help
with cardiovascular health and type 2 diabetes prevention in both pre-clinical and clinical
populations (17). For the purposes of this paper we will review Running-SIT (R-SIT)

protocols that resemble the methods studied here, but because of limited available research,
HIIT and cycling SIT studies will be referenced for additional comparison.
Cardiovascular Disease and Framingham Scores

CVD is the leading cause of death in the United States, accounting for approximately

1.2 million deaths from 2010-2011 (40). CVD is defined by the American Heart Association
as problems related to atherosclerosis or plaque buildup that restrict blood flow in the
arteries (41). The major risk factors for CVD are dyslipidemia, hypertension, physical

inactivity, obesity, type 2 diabetes, insulin resistance, and smoking (42). An individual’s risk
can be controlled or reduced with regular exercise, weight control, diet, and smoking
cessation (42).
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In 1948, the National Heart, Lung, and Blood Institute (NHLBI) partnered with

Boston University to learn more about the causes of CVD, resulting in what is now an ongoing study known as the Framingham Heart Study (43). The original cohort had 5,209
participants and followed individuals over the course of several years to identify what

common characteristics resulted in CVD. Participants returned every two years for a detailed
physical examination. In 1971, a second cohort of 5,124 individuals was enrolled. These new
participants were children of the original participants, allowing for long-term hereditary

effects to be studied. Since the inception of the two original cohorts there have been four

more added and studied: the Omni Cohort (1994), Third Generation Cohort (2002), New

Offspring Spouse Cohort (2003), and Second Generation Omni Cohort (2003). As a result

of the valuable information gathered from this on-going study, the Framingham Risk Scores
were developed in 1998. These algorithms rate the risk of different outcomes, such as atrial
fibrillation, CVD, congestive heart failure, coronary heart disease, diabetes, hypertension,
intermittent claudication, and stroke (44).

For the purposes of this study we will assess baseline, midline, and post scores of

participants’ CVD risk in the next 10 years. The CVD risk calculator uses age, gender, total
cholesterol, HDL-C, smoking habits, and systolic BP to estimate the risk of non-diabetics
(fasting blood glucose at or below 125 mg/dL) between the ages of 30-74 who have no
previous heart disease diagnosis. Potential CVD outcomes predicted by the score are

coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke,

hemorrhagic stroke, transient ischemic attack, peripheral artery disease, and heart failure.

To our knowledge there are no HIIT or SIT studies that have documented pre and

post-Framingham scores.
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Blood Lipid Profile

Poor lipid values are highly correlated with instances of atherosclerosis. High

triglycerides (TG) and low HDL-C are risk factors for CVD (3, 25, 45, 46). High HDL-C is
known to have an atheroprotective role because of its ability to carry cholesterol from the
vascular system and arterial walls to the liver for excretion (25). The chance of a cardiac

event is five times greater in someone who has a total blood cholesterol over 259 mg/dL as
opposed to someone whose total blood cholesterol is under 200 mg/dL (47).

Exercise is known to have a positive impact on cholesterol and as a result is often

prescribed to patients at risk for CVD (12, 27). It increases HDL-C concentration and, as is
suggested by some of the literature, it also may lower total cholesterol and low-density

lipoproteins cholesterol (LDL-C). Additionally, exercise has an atheroprotective effect by

increasing the mean size of HDL-C and LDL-C particles. Small particles are known to be
related to complications of the disease process (12). Lastly, exercise reduces plasma TG
concentrations, especially exercise in a postprandial state. Reduced plasma TG

concentrations are likely the underlying mechanism for the effect exercise has on the size of
HDL-C and LDL-C, and HDL-C concentration (12). A decrease in TG concentrations may
be a result of TG clearance in the skeletal muscle and a decreased hepatic production of

very-low-density lipoproteins (VLDL-C) (11). Though changes in TG concentrations are

acute and likely associated to the energy expenditure, repeated bouts of exercise often lead to
a more favorable blood lipid profile (12).

Results of current SIT and HIIT studies are mixed in regards to changes in blood

lipid profiles, and the exact impact of interval training has yet to be defined. This could be a
result of differing methodology, though the main reasons are likely short intervention time
(24) and/or healthy participants with normal blood lipid profiles at baseline (8, 22, 25).
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Additionally, timing of meals and diet may exacerbate these discrepancies (26). Regardless,
studies that incorporate blood lipid profiles are limited.

Of the studies reviewed with blood lipid comparisons, there are three that involved

running interval interventions, all with differing results. Sandvei et al. reported that eight

weeks of R-SIT improved total cholesterol in healthy young participants when compared to
the control group. The study observed a 9% improvement in LDL-C but no changes in

HDL-C (8). Alternately, a six-week R-SIT study conducted on a group of 15 recreationally

active females reported no change in LDL-C, TG, or total cholesterol and a small decrease
in HDL-C (22). Lastly, Musa et al. observed an 18% improvement in HDL-C and no
significant changes in total cholesterol after eight weeks of R-HIIT at 90% HR max on

untrained young men (25). The study concluded that significant improvement of HDL-C

was likely the result of unfavorable baseline concentrations. It should be noted that this R-

HIIT study was conducted on an outdoor track instead of a treadmill, as is typically seen in

the literature. The little-to-no changes observed in other blood lipid markers of all of these
R-SIT studies were likely due to the healthy sample pool and otherwise normal baseline
levels (8, 22, 25).

To our knowledge there are no R-SIT or R-HIIT studies with clinical participants

that consider blood lipid profiles. Of the studies there are three cycling interventions on

clinical and obese/overweight participants (13, 24, 30). The results of these studies are also
mixed. Keating et al. reported that 12 weeks of HIIT on overweight adults had significant
improvements in total cholesterol and LDL-C when compared to a continuous exercise

group. However, the study found no significant interaction between TGs and HDL-C (13).
Alternatively, Heydari et al. found no significant change in blood lipids after 12 weeks of

HIIT on inactive overweight males, however the study indicated that participants’ baseline
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levels were within the normal range (30). Similarly, Whyte et al. also reported no change in
total cholesterol or HDL-C after two weeks of SIT on sedentary overweight/obese men

(24). It should be noted, though, that this study lasted only two weeks and according to the
researchers a longer intervention may be needed to see the chronic adaptations of exercise.
Kraus and colleagues took a different approach in analyzing lipid changes and its

relationship to intensity. Their research compared the effects of six months of high-amounthigh-intensity (the caloric equivalent of jogging 20 miles per week at 65-80% VO 2peak), low-

amount-high-intensity (the equivalent of jogging 12 miles per week at 40-55% VO 2peak), lowamount-moderate-intensity exercise (the equivalent of walking 12 miles per week at 40-55%
VO2peak), to a control group of overweight men and women and found that changes in

lipoproteins were independent of exercise intensity (15). They reported that all exercise

groups had improvements in TG concentration, concentration of VLDL-C, concentration of
large VLDL-C particles, and size of VLDL-C particles. Additionally the high-amount-highintensity group had significantly-reduced concentrations of LDL-C and small LDL-C

particles, and increases in HDL-C concentration. Both high and low-intensity groups also
observed increases in the average size of LDL-C particles. It is important to note that

though this research was not a typical R-HIIT protocol, the lipid profiling methods used
may prove more valuable than a standard lipid panel in clearing up contradicting HIIT

evidence. Of the results reported, only HDL-C and TG would have been detected in a
standard lipid panel and according to the researchers “the concentrations of LDL-C

particles, small LDL-C particles, large HDL-C particles, and large VLDL-C particles are
better indicators of CVD risk than are the elements of the traditional lipid profile” (15).
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Blood Pressure

As with the previous variable, hypertension is an important risk factor for CVD.

Since a change in BP is a function of cardiac output times total peripheral resistance (Δ

pressure = cardiac output x total peripheral resistance), an increase in BP is the result of

changes in cardiac output or total peripheral resistance. Elevated BP progressively causes

cellular damage and hardening of the arteries, which results in a reduction of stroke volume
and maximal oxygen consumption. This reduction in stroke volume causes an overall
decrease in cardiac output, leading to an increase in peripheral resistance (42).

However, hypertension can be controlled with medication, diet, weight control and

exercise, and all are common prescriptions for cardiac rehabilitation. Notably, the inclusion
of exercise can mitigate the use of medications and often results in improved body

composition (42). Exercise training has been proven to decrease both systolic and diastolic

BP with more pronounced results in hypertensive patients (14, 32, 42). Improvements in BP
as a result of training are related to the changes in the sympathetic nervous system (and

potentially the renin-angiotensin system) that cause a decrease in total peripheral resistance
(14). According to Foss, the traditional expected decrease as a result of training is about

~10mmHg and ~8 mmHg in systolic and diastolic, respectively (47). As little as a 5mmHg
decrease in BP can translate to a 14% reduction in stroke mortality and a 9% reduction in
CVD mortality (14).

Information on HIIT and BP is limited, though studies with clinical populations and

higher baselines often resulted in improved BP (16, 32, 35). Though different variables of BP
are considered, studies reviewed for these purposes indicated a reduction in both systolic and
diastolic BP (16): a decrease in resting diastolic BP, exercise diastolic BP, recovery systolic

BP, and recovery diastolic BP in normotensive women (with a family history hypertension)
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(32); and a reduction in systolic ambulatory BP and diastolic ambulatory BP in hypertensive
patients (35).

Body Composition

Obesity, particularly excess abdominal fat and visceral adipose tissue, is known to be

linked to health-related problems including CVD, type 2 diabetes, and increased mortality (2,
13, 16). Obesity is associated with insulin resistance, poor lipid profiles, impaired cardiac
function during exercise, decreased GLUT 4 transporters, impaired immune function,

depression, chronic pain, and impaired mobility (2, 42). A modest weight loss of 5-10% of
an individual’s starting body weight can decrease body fats as well as improve glucose

control (42). Furthermore, regular exercise can improve overall body composition (including
visceral fat) independent of weight loss (13). Metabolically, exercise induces increases in

epinephrine, norepinephrine, and growth hormone resulting in hormone-stimulated lipolysis.
This leads to an increase in fatty acid availability and thus an increase in fatty acid uptake and
oxidation for energy (13, 16). Acute bouts of HIIT appear to significantly increase these
hormones, and since visceral fat is particularly sensitive to these hormones, it has been
suggested that HIIT may be an effective method in improving body composition and
reducing visceral fat (13). However, research regarding the effects of HIIT on body

composition is limited and mixed, especially on clinical populations. Furthermore, because
the total amount of fatty acid oxidation during and after exercise is not only a result of

availability and uptake but a function of the activity’s duration, more research is needed to
definitively compare the efficacy of HIIT to prolonged traditional exercise (13).

Observations of HIIT and SIT studies with overweight/obese participants include decreases
in BMI (2, 16), waist circumference (16, 30), waist to hip ratio (2), body fat percent (BF%)

(2), trunk fat (30), android fat (30), weight (16, 30), fat mass (30), visceral fat (30), increases
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in fat free mass (30), and changes in body mass (2, 48). To our knowledge this is the first RSIT study to look at body composition in prediabetics.

The most relevant running protocol with clinical participants found that after 16

weeks of running-HIIT (R-HIIT), weight was reduced by three and four percent by the RHIIT and moderate intensity groups, respectively (16). Likewise, BMI and waist

circumference were significantly reduced in both groups with no significant differences
between the groups. It should be noted, however, that the purpose of this study was to

compare the modes independent of the time, thus training volumes were equalized to similar
amounts of kilocalories per session so that R-HIIT exercised for 40 minutes while the
moderate intensity group exercised for 47 minutes.

Similarly, after 12 weeks of R-HIIT, Tan et al. found that body mass, BMI, BF%,

and Waist-to-Hip Ratio (WHR) were significantly reduced in both R-HIIT and moderate

intensity group in overweight college age women (2). Most notably, there was a 9.9% body

fat loss in the R-HIIT group, which was significantly more when compared to a 5.2% loss in
the moderate intensity group. The researchers concluded that R-HIIT “can be of great help
to these obese people by decreasing the accumulation of fat tissue in different parts of the

body while the low intensity exercise training has failed to produce any notable change” (2).
It is important to mention that during the 12 weeks participants of this study exercised five

times per week on an outdoor track as opposed to the typical three times on a treadmill seen
in most R-HIIT and R-SIT studies, which could account for some of the results observed.
Alternatively, Keating et al. found that there were no significant changes between

continuous exercise and HIIT groups in waist and hip circumferences, body mass, total lean
mass, and gynoid fat. Additionally, they observed significant differences between groups in
trunk fat, android fat, and total body fat. Both trunk and android fat increased in HIIT and
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decreased in the continuous exercise group, while total body fat stayed the same in HIIT and
decreased in the continuous exercise group. The researchers of this study concluded that
continuous exercise, not HIIT, improves fat distribution in overweight adults (13).
Insulin Resistance

As abdominal adiposity increases there is usually an increase in insulin resistance (3,

12). It is this relationship between obesity and insulin resistance that plays a major role in
CVD and diabetes (3, 12, 49, 50). Diabetes accelerates the atherosclerotic process and

patients diagnosed with type 2 diabetes are two-to-five times more likely to have a cardiac

event when compared to their non-diabetic counterparts (12, 19, 49). As a result, CVD is the

leading cause of death in type 2 diabetics (49). Furthermore, HOMA-IR, a measure of insulin
resistance, is considered a strong and independent predictor of CVD (49-51).

Cardiovascular disease risk can be reduced with exercise as a result of its positive

effects on insulin resistance. After a single bout of exercise there is an increase in insulin

sensitivity, an effect that has been observed for up to two days following the initial activity.

The magnitude and impact of this effect is increased by periods of continuous exercise (12).

The mechanical movement of exercise causes a release of calcium, which begins a cascade of
signals ultimately leading to the translocation of GLUT 4 to the cell membrane (12, 19). The
key in this process is that the mechanical translocation happens independent of insulin and

as a result there is an acute increase of glucose uptake in the skeletal muscle, regardless of a
person’s insulin sensitivity status (12, 19). The control of blood glucose through regular

exercise and weight loss can help lower the risk of type 2 diabetes by up to 58% in high-risk
populations (19).

Evidence that HIIT and SIT provide additional benefits to insulin resistance when

compared to traditional exercise is varied. A systematic review conducted by Sloth et al.
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reported that SIT may have beneficial results to insulin sensitivity and glycemic control, but
noted that HIIT and SIT studies conducted on clinical populations are limited (10).

Furthermore, it has been suggested that subjects with metabolic abnormalities may show
greater improvement because of a lower baseline than their healthier counterparts (32).

Tjonna et al. and Ciolac et al. both reported improvements in insulin sensitivity in

interval groups with metabolic abnormalities (16, 32). These studies suggested that the

improvement in insulin sensitivity from interval training may be attributed to an increase in
β-cell function resulting from an enhanced insulin response and signaling. Furthermore,

interval training improved activation and phosphorylation of the insulin receptor in both
muscle and fat. Though the mechanism in muscle is not fully understood, it’s generally

accepted that there is a decrease in intracellular accumulation of triglycerides and increase in
fatty acid oxidation, resulting in an increase of insulin’s action (16, 32). Additionally there is
an increase in mitochondrial biogenesis with interval training (13, 16).
VO2max

VO2max is known to be the best measure of a person’s cardiovascular fitness and

mortality. Reports from epidemiological studies indicate that low fitness and low VO 2max
levels are often related to higher CVD rates and are strong predictors of future cardiac

events (5, 35). Additionally it is also a measure of a person’s oxidative phosphorylation
capabilities, meaning that VO2max reflects the highest rate of energy that an individual

receives from aerobic metabolism. Improvements in VO 2max are a result of improved cardiac
output as well as increased muscle oxidative potential (10). Improved cardiac output

increases the oxygen that is available to the body, while the ability to extract the oxygen is a
result of enzymatic and mitochondrial muscle adaptations. Intense interval training elicits
rapid changes by challenging the aerobic energy system (10).
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Typically, results from HIIT and SIT studies have shown improvements in VO 2max,

with some studies showing a significantly higher improvement when compared to a

moderate exercise group (5, 6, 8, 10, 16, 22, 24, 30-35). According to a review published by
the Scandinavian Journal of Medicine & Science in Sports, there is enough evidence to

support that 2 to 8 weeks of SIT will improve VO 2max in populations that have been studied,

including sedentary, untrained, overweight/obese, as well as recreationally active individuals.
Typical increases of about 4 to 13.5% were seen in most SIT studies (10).

A second meta-analysis conducted by Gist et al. reported an average 8% increase in

VO2max in the SIT intervention group when compared to the no-exercise control (5). The
study went on to indicate that the improvements seen in oxidative capacity and exercise
performance are similar to those seen in traditional endurance groups of moderate-to-

vigorous intensity, however the training volume of the SIT group was only 10% of the
endurance training group (5). Gist et al. also noted that though training volume was

significantly less, warm up, active recovery, and cool down time will obviously increase the
person’s activity time, reducing the time-efficient appeal of HIIT and SIT (5).

R-SIT and R-HIIT studies conducted on clinical populations have shown similar

improvements in VO2max, with some studies reporting better results than the endurance or
control group (2, 16, 35). Tjonna et al. suggested that intensity plays an important role in

improving aerobic capacity, resulting in a higher reduction of risk factors, with 46% of the

interval participants no longer having the metabolic syndrome diagnosis, compared to 37%
of the moderate intensity group (16).
Diabetes Prevention Program

The Diabetes Prevention Program (DPP) began as a randomized control trial with

3,234 participants at 27 different centers, and has continued as an ongoing lifestyle
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intervention program geared towards diabetes prevention in individuals with prediabetes or
at risk for developing type 2 diabetes. The initial goals of the study were to determine if

lifestyle changes or drug therapy (metformin) would have a greater effect on participants
(52). Primary results from the program are in line with other organizations such as the
American Diabetes Association and ACSM and indicate that people at risk for type 2

diabetes can avoid or delay the onset with the addition of physical activity, weight loss, and
diet changes that include a reduction in fat and calories. Initial DPP findings revealed that

lifestyle intervention reduced type 2 diabetes by 58% when compared to 31% observed with
the metformin intervention (52). Adults 60 or older that participated were particularly
successful, reducing their risk by 71% (53).

Participants of both groups (R-SIT and MIT) of this study received DPP education

with lifestyle coaches. The program was broken down into 16 sessions that covered nutrition
education, lifestyle changes, stress management, and motivation (54). The first eight weeks
of the program were geared towards teaching participants fundamental information about
caloric intake and exercise. During the second eight weeks the focus shifted towards

psychological, social, and motivational components (52). These are important to help ensure
long-term lifestyle modifications in maintaining healthy habits.
Summary

As the obesity epidemic in the US continues to grow, exercise training is a common

prescription because of its known benefits and central and peripheral adaptations (5-7, 9,

10). The most commonly-cited reason for poor physical fitness is a lack of time (7, 9, 13, 2224). As a result, protocols such as SIT and HIIT are being studied as time-efficient solutions

with similar benefits to those seen in traditional exercise programs. Improvements in VO 2max
have been reported by most studies(5, 6, 8, 10, 16, 22, 24, 30-35), but results of other
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cardiovascular markers such as BP, body composition, glycemic control, and blood lipid

profiles are inconclusive. The mixed results could be due to differences in the protocols,

methods (interval times, rest times, study duration) and participants. Additional research to
understand the cardiovascular benefits of SIT and HIIT is needed, especially on clinical
populations.

An epidemiological study that looked at the participants of the Framingham Study

concluded that the risk factors associated with CVD are increased 30 years before the

individual is diagnosed with type 2 diabetes (45). This suggests that control of the risk

factors, particularly glycemic control, hypertension, dyslipidemia and smoking cessation,
should start early in life, and improvements on these factors could potentially decrease
instances of CVD and type 2 diabetes.
Limitations of Current Research

The majority of HIIT and SIT studies have been done on healthy, physically active,

and/or athletic individuals (7, 9, 13). Minimal work has been done on clinical populations,
specifically prediabetic, type 2 diabetic, overweight, or obese participants. Additional

research in this area may prove valuable since benefits and adaptations observed in studies
on clinical populations may differ as a result of poor baseline measures. Furthermore,

research within this population will have added benefits since generally this is the group that
needs to improve baseline measures.

Another limitation of current studies is that the majority use cycle ergometer

protocols instead of running protocols (2, 6, 8, 16, 22, 32, 35). Running is considered to be
an easily accessible, affordable, and a popular mode of exercise for many. Consequently,

there is little data on the adaptations resulting from R-SIT and R-HIIT. Additionally, the

data that is seen in cycle protocols may not translate to the same results in running (8, 22).
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Lastly, there is limited, and often mixed, information on variables such as body

composition, insulin resistance, blood lipids, and BP. Differences observed in the literature
could be a result of the timing of the intervals and active recovery periods, sample sizes,
study duration, sample demographics, differences at baseline, and intervention mode.
Purpose

The purpose of this study was to determine if the reduction of the 10-year risk of CVD

(determined by Framingham CVD risk calculator), is greater in an R-SIT experimental group
compared to a moderate intensity group (MIT) of sedentary prediabetic women, after a 16week intervention.
Hypothesis

It was hypothesized that 16 weeks of run spring interval training would show greater

improvements in 10-year CVD Framingham Risk Score, body composition, VO 2max, blood

pressure, and blood lipid values compared to moderate intensity training and control groups.
Assumptions

Assumptions for this study include: participants would be able to perform all-out maximal
efforts on a treadmill; participants would not engage in other regular exercise programs

outside of the intervention; participants were healthy with no previous CVD, pulmonary, or
metabolic diagnosis.
Limitations

Seasonal changes were a limitation to this study. As the weather got colder, participants may
have been less likely to spend time outside, which could have resulted in an average

reduction of unstructured activity (55). Furthermore, holidays that occurred during the 16week span (Thanksgiving to New Year’s) may have negatively impacted participants’ body
weight, BF%, and BP (56).
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Delimitations

A delimitation for this study is that the prediabetic sample were only recruited from the
Harrisonburg, VA area.
Definitions

Cardiovascular Disease (CVD): As defined by The American Heart Association, problems

related to atherosclerosis or plaque buildup that restrict blood flow in the arteries. CVD is

also known as heart disease and includes heart attack, ischemic stroke, hemorrhagic stroke,
heart failure, arrhythmia, mitral valve prolapse and heart valve disease.

Diabetes Prevention Program (DPP): A research study led by The National Institute of Health
(NIH) with assistance from The Center for Disease Control and Prevention (CDC) that

resulted in a lifestyle intervention program geared towards diabetes prevention in prediabetes
or at those at high risk for developing type 2 diabetes.

Framingham Risk Score: As defined by The National Heart, Lung, and Blood Institute and

Boston University, a score that predicts the chances (in percent) that an individual (non-

diabetic and no prior history of heart disease) will have CVD (coronary death, myocardial
infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient
ischemic attack, peripheral artery disease, heart failure) in the next 10 years. The score is
based on age, gender, total cholesterol, HDL-C, smoker, and systolic BP (treated and

untreated). For purposes of this study, the risk score will be calculated using a downloaded
excel calculator from https://www.framinghamheartstudy.org (Appendix A).
Prediabetes: As defined by The American Heart Association,


Hemoglobin A1C test: glycated hemoglobin indicative of blood glucose levels over a
period of time, result within a range of 5.7-6.4
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Fasting Blood Glucose Test (FBG): 8 hour fasting blood sugar within a range of
100-125 mg/dl

Oral Glucose Tolerance Test (OGTT): results within a range of 140-199 mg/dl

Sedentary: As defined by the ACSM, an individual who does not participate in at least 30
minutes of physical activity at 40-50% VO2R at least 3 times per week.
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Research Design

Chapter II

This study was a 16-week randomized controlled trial. Participants were randomly

divided into two groups: Running-Sprint Interval Training (R-SIT) or Moderate Intensity
Training (MIT). Additionally, all participants attended 16 weeks of Diabetes Prevention
Program (DPP) education with trained lifestyle coaches. Data was collected at baseline,

midline, and post intervention and included: Framingham Risk Score, vascular age, Blood

Pressure (BP), Total Cholesterol (TC), High Density Lipoprotein Cholesterol (HDL-C), Low
Density Lipoprotein Cholesterol (LDL-C), Very Low Density Lipoprotein Cholesterol

(VLDL-C), Triglycerides (TG) body weight, height, body composition, and cardiovascular

fitness level (VO2max). This study was approved by The Institutional Review Board at James
Madison University.
Statistical Analysis

All statistical data were analyzed using IBM SPSS 21.0 statistical software package

(Armonk, NY). Data was analyzed via repeated-measures ANOVA. Paired sample and
independent sample t-test were used to compare the relationship of the variables.
Significance level was set a priori at p < 0.05.

As part of a larger study, participant randomization was based on gender, age, and

Body Mass Index (BMI), limiting the ability of the present study to randomize for age and
baseline risk of CVD.

Participants and Recruitment

Sedentary prediabetic men and women were recruited and screened throughout

Harrisonburg, VA. Recruitment included ads in the local Harrisonburg paper, a bulk email

dispersed to the James Madison University community (faculty, staff, and students), a public
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service announcement that aired on a local channel, fliers posted around the community, and
a Facebook page. As defined by ACSM, sedentary individuals are those who do not

participate in at least 30 minutes of physical activity at 40-50% VO 2R at least three times per
week. Participants were screened to ensure that they met the requirements to participate in
the study. They were classified as “low” or “moderate” risk according to ACSM risk

categories and had to be able to perform all-out efforts on a treadmill. Additionally, they had
to be in overall good health with no previous CVD, pulmonary, or metabolic syndrome
diagnosis. Participants were excluded if they could not perform the activities, were not

physician-diagnosed prediabetic, were not of mental capacity to consent, or were pregnant
and/or breastfeeding.

Thirty-one sedentary, prediabetic men and women were recruited and randomly

allocated to either MIT (n=13) or R-SIT (n= 18) groups (see Figure 1). Twenty-four

participants completed midline testing (MIT=10, R-SIT=13) and 16 participants completed
the 16-week intervention (MIT=10, RSIT=6). From baseline to post-testing four dropped
due to an unrelated injuries, two due to medial tibial stress syndrome, two reported ankle
and knee pain, five due time constraints, and two for an unknown reasons. Five male

participants completed the screening and recruiting process. Of the five only one completed
the 16-week intervention, as a result, the data presented in this study only includes female
participants.

Testing Meetings

-Familiarization Meeting (baseline): In the initial meeting participants met with researchers in the
Kinesiology Human Performance Lab (Godwin, room 217) to discuss procedures, risks, and
questions. Participants completed the Informed Consent form (Appendix B), the Physical
Activity Readiness Questionnaire form (PAR-Q) (Appendix C), the Health Status
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Questionnaire form (Appendix D), the International Physical Activity Questionnaire (IPAQ)
(Appendix E), and received Three Day Food Intake Records (to be completed at home
during two weekdays and one weekend day) (Appendix F). The researchers provided

participants with detailed verbal and written instructions (Appendix F) on how to accurately
collect Three Day Food Intake Records. A follow-up meeting with the participants was
scheduled for a later date to review recorded food intake data. Lastly, participants were
required to get a Physician Approval Form (Appendix G) and either provide it at the

Familiarization Meeting or return with the completed form. Physician approval was required
prior to any exercise, and if presented at this time, participants could begin fitness and

anthropometric testing at this meeting (described below). If not, a follow-up fitness and
anthropometric testing meeting was scheduled.

-Fitness and Anthropometric Testing (baseline, midline, and post): Testing was performed in the

Kinesiology Human Performance Lab (Godwin, room 217). Participant’s resting BP, weight,
height, and body composition were recorded. BP was measured using a Prosphyg Standard
Aneroid cuff (Adcuff TM, Hauppauge, NY) and an Adscope-lite stethoscope (Hauppauge,

NY). Body composition was collected using a GE Lunar iDEXA (Madison, WI). Height was
measured with Charder Height Measurement Model HM 200P (Issaquah, WA). The scale
used to measure weight was a SECA (Chino, CA). Additionally, participants completed a
VO2max test on a Cosmos Treadmill (Nussdorf-Traunstein, Germany) using ParvoMedics

TrueOne Metabolic System (Sandy, UT). Protocol used for testing was the Modified Balke
(57). The test consisted of a three minute warm-up followed by 2.5% grade increase every

three minutes at a self-selected speed that the participant could maintain for the duration of

the test. The test proceeded until maximal effort was accomplished or until volitional fatigue.
Maximal effort was considered accomplished when participants reached one or all of the
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following: 19-20 on the RPE scale, Respiratory Exchange Rate (RER) on the metabolic cart

reached 1.1 and/or the participant was within 10 beats of age-predicted max heart rate. This
protocol was selected because it is recommended by ACSM for older or deconditioned
participants with chronic diseases (57). During the test HR was monitored using Polar

Watch and Polar Electro and recorded every minute after the third minute. Additionally, BP

and Rate of Perceived Exertion (RPE) were recorded every third minute. RPE was based on
Borg’s scale in which the participant rates the exercise on a scale of 6-20, ranging from
extremely light exertion to maximal exertion (42).

-Clinical Testing (baseline, midline, and post): On a separate day (from fitness and anthropometric
testing) participants were instructed to visit one of four SRMH location for a blood draw

administered by a certified phlebotomists. Participants were required to fast for 8-10 hours
and refrain from exercise for 24-hours prior to their appointment. Blood draws were

analyzed at SRMH and results were faxed on a secure line to researchers. Framingham Risk
Score was calculated using a calculator (Appendix A) downloaded from

www.framinghamheartstudy.org (43) and the results from the blood draws.

-Three Day Food Intake Records (baseline, midline, and post): The researchers provided participants
with detailed verbal and written instructions for Three Day Food Intake Records at the

familiarization meeting. Completed food records were then collected at baseline, midline,

and post intervention and reviewed by the researchers and participant in a separate meeting.
The purpose of this meeting was to ensure that all items were recorded as accurate as

possible. Food intake records were analyzed at a later date using University of Minnesota
Nutrition Data System for Research 2012 (Minneapolis, MN).
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Figure 1: Timeline of 16-Weeks for R-SIT and MIT Sedentary Prediabetic Participants

Intervention Protocols

DPP and training interventions lasted 16 weeks. Participants had the option of attending one
of two weekly DPP meetings available at SRMH or Godwin Hall. DPP meetings typically
lasted one hour and all participants were expected to be compliant with the program.
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Additionally, participants met three times per week for 34-84 minutes for supervised

trainings in Godwin, room 116 A/B. Both training protocols were broken up into four
progressing blocks consisting of four weeks per block (see Table 1).

R-SIT Group: Prior to all exercise resting BP and resting HR were recorded in the seated

position. Participants began each training with a warm-up that consisted of five minutes of

dynamic stretching plus five minutes of walking on the treadmill at a self-selected speed with

no incline (0% grade). Total warm-up time was 10 minutes. Immediately following warm-up,
participants began interval training. One interval was defined as 30-seconds of all-out sprint
at a self-selected speed and grade, followed by four minutes of active recovery at self-

selected speed and 0% grade. Participants received encouragement from the researchers to

sprint as fast as possible to ensure that maximal effort and heart rate was achieved. HR was

recorded at the end of each active recovery and at the end of each sprint. RPE was recorded
at the end of each sprint. Once all session intervals were completed, participants ended each
session with a five minute treadmill cool down at a self-selected speed and 0% grade.

Immediately following every treadmill cool down, final HR and RPE for the entire session

were recorded. Participants then completed five minutes of dynamic stretching. Total cool

down time was 10 minutes. Resting BP was measured after cool down and a brief period of

seated rest. Every four weeks the training progressed with the addition of two intervals. The
progression was as follows: weeks 1-4, four intervals; weeks 5-8, six intervals; weeks 9-12,
eight intervals; and weeks 13-16, 10 intervals.

MIT Group: Prior to all exercise resting BP and resting HR were recorded in the seated

position. Participants began each training with a warm-up that consisted of five minutes of

dynamic stretching plus five minutes of walking on the treadmill at a self-selected speed with
no incline (0% grade). Total warm-up time was 10 minutes. Immediately following warm-
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up, participants began moderate intensity training at 45-55% Heart Rate Reserve. This was

calculated by subtracting resting HR and maximal heart rate. The result was then multiplied
by 45-55% and added to resting HR to ensure target HR (47). HR was recorded every five
minutes. Once participants reached the time goal for the session, they began a five minute
treadmill cool down at a self-selected speed and 0% grade. Immediately following every

treadmill cool down, final HR and RPE for the entire session were recorded. Participants

then completed five minutes of dynamic stretching. Total cool down time was 10 minutes.
Resting BP was measured after cool down and a brief period of seated rest. Every four
weeks the training progressed with the addition of 10 minutes. The progression was as

follows: weeks 1-4, 30 minutes; weeks 5-8, 40 minutes; weeks 9-12, 50 minutes; and weeks
13-16, 60 minutes.
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Table 1: Breakdown of Training Sessions

R-SIT

MIT

Warm-Up
5 minutes dynamic stretching
5 minutes treadmill walking

Weeks 1-4: 4 intervals
Weeks 5-8: 6 intervals
Weeks 9-12: 8 intervals
Weeks 13-16: 10 intervals

Weeks 1-4: 30 minutes
Weeks 5-8: 40 minutes
Weeks 9-12: 50 minutes
Weeks 13-16: 60 minutes

Active Time
(Total Sprint Minutes + Total Recovery
Minutes)
Weeks 1-4: 14 minutes (2+12)
Weeks 5-8: 23 minutes (3+20)
Weeks 9-12: 32 minutes (4+28)
Weeks 13-16: 41 minutes (5+36)

Active Time
Weeks 1-4: 30 minutes
Weeks 5-8: 40 minutes
Weeks 9-12: 50 minutes
Weeks 13-16: 60 minutes

Cool Down
5 minutes treadmill walking
5 minutes dynamic stretching

Total Time
Weeks 1-4: 34 minutes
Weeks 5-8: 43 minutes
Weeks 9-12: 52 minutes
Weeks 13-16: 61 minutes

Total Time
Weeks 1-4: 50 minutes
Weeks 5-8: 60 minutes
Weeks 9-12: 70 minutes
Weeks 13-16: 80 minutes
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Chapter III

Title

A 16-Week Run Sprint Interval Training Does Not Have an Effect on Cardiovascular Risk
Measured by Framingham Risk Score on Prediabetic Women
Abstract

The Framingham Risk Score (FRS) was developed to determine the likelihood of

developing cardiovascular disease (CVD) in the next 10 years using an individual’s age,

gender, total cholesterol (TC), High Density Lipoprotein Cholesterol (HDL-C), smoking

habits, and systolic blood pressure (SBP). Run-Sprint Interval Training (R-SIT) has shown
improvements in various health and blood markers while reducing total exercise time. To

date there has not been a study that examines the effects of R-SIT and Moderate Intensity
Training (MIT) on Framingham Risk. The purpose of this study was to determine if a

reduction of the 10-year risk of CVD (determined by Framingham CVD risk calculator), is
greater in an R-SIT experimental group compared to a moderate intensity group (MIT) of
sedentary prediabetic women, after a 16-week intervention. Participants were randomized

into R-SIT (n=6) or MIT (n=9) groups and required to attend 3 weekly training sessions and
1 weekly Diabetes Prevention Program session for 16-weeks. During the first 4 weeks, RSIT performed 4x30s maximal sprints on a treadmill at a self-selected speed and incline,
followed by a 4-min active recovery between intervals. Intervals increased by 2 every 4

weeks. MIT walked continuously at 45-55% Heart Rate Reserve for 30-mins during the first
4 weeks, and increased by 10-mins every 4 weeks. FRS markers were measured at baseline,
mid, and post intervention.
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After 16-weeks of exercise training, there was a significant time by group interaction

in weight, Body Mass Index (BMI), and Body Fat Percent (BF%). T-tests indicate MIT
significantly decreased in weight (-2.60+1.32 kg), BF% (-1.58+1.54), and BMI

(-2.42+1.32 kg). R-SIT significantly changed in BF% from baseline to mid (-2.33+0.72) and
mid to post (+1.53+0.46), but not from baseline to post (-2.16+2.53). Additionally, there
was a trend toward significant improvements in BMI (p=0.078) and lean body mass

(p=0.059) (-0.85+0.06 kg/m2, +1.05+0.46 kg, respectively). Lastly, R-SIT participants also

significantly decreased changes in TGs from midline to post (-23.33+17.92 mg/dL). Though
FRS and Vascular Age (VA) were significantly different between groups at all three time
points, there were no significant within-group changes observed

The major findings of this study were that after 16-weeks of exercise training, MIT

had significant within-group decreases for weight, BMI, and BF%, while R-SIT significantly
decreased BF% and increased VO2max (mLkg-1min-1). In conclusion, though previous R-SIT

and HIIT studies have suggested improved body composition and cardiovascular risk factors
when compared to MIT, the present study only observed significant changes in body

composition and minimal changes to CVD risk factors. Additional research is needed to
further understand the effects of R-SIT on blood lipid profiles and its relationship with
CVD, especially in the clinical population.
Keywords:

Framingham Heart Study; Cardiovascular Disease (CVD); High Intensity Interval Training
(HIIT); exercise intensity; interval training; diabetes
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Introduction

According to the Centers for Disease Control and Prevention (CDC), more than one

third of the American adult population are obese (1). Often there is a correlation between

obesity and sedentary behavior (2, 3). Consequently, obesity and inactivity are independently
known to be associated with health related problems such as cardiovascular disease (CVD),

stroke, insulin resistance, and type 2 diabetes, as well as, certain types of cancer, reproductive
abnormalities, and osteoarthritis (2-8). Furthermore, according to a study published by the
American Diabetes Association, risk factors associated with CVD are increased 30 years

before the individual is diagnosed with type 2 diabetes (45). This suggests that control of the
risk factors, particularly glycemic control, hypertension, dyslipidemia and smoking cessation,
should start early in life, and improvements on these factors could potentially decrease
instances of both CVD and type 2 diabetes.

In 1948, the National Heart, Lung, and Blood Institute (NHLBI) partnered with

Boston University in what ultimately became the Framingham Heart Study (43). The original
cohort had 5,209 participants and followed individuals over the course of several years to

identify what common characteristics resulted in CVD. Over the course of the study, risk

factors such as dyslipidemia, hypertension, physical inactivity, obesity, type 2 diabetes, insulin
resistance were identified. This valuable information lead to the development the

Framingham Risk Calculators and Scores (FRS). The algorithms rate the risk of different

outcomes, such as atrial fibrillation, CVD, congestive heart failure, coronary heart disease,

diabetes, hypertension, intermittent claudication, and stroke and determines an individual’s
risk of developing the conditions in the next 10 or 30 years (44).

Improved fitness has proven benefits to cardiovascular health and the prevention of

metabolic diseases such as CVD and type 2 diabetes (2, 3, 11-15). Furthermore, exercise is
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considered a direct, cost-effective way of improving overall health (5-7, 9, 10) and can

reverse or impede some of the adverse effects associated with metabolic syndrome (16).

Benefits of exercise training include reduced blood pressure (BP), increased high-density
lipoprotein cholesterol (HDL-C), improved body composition, and improved maximal

oxygen uptake (12, 14, 17, 19-21, 52, 58). Despite exercise being a cost-efficient and effective
intervention for many chronic diseases that Americans face, approximately 22% participate
in regular exercise at any intensity (21). The most- cited reason for poor participation in

exercise programs, regardless of age, sex, ethnic background, or health status (17), is a lack of
time (7, 9, 13, 22-24). As a result, more research has focused on reducing the time involved

in physical activity, while maintaining and/or improving aerobic and metabolic benefits seen
with traditional exercise programs (7, 9, 13, 22-24).

High intensity interval training (HIIT) is an exercise protocol that has recently been

the subject of many research studies (2, 5, 7-10, 16, 22, 25-37). HIIT is defined as intense

periods of intermittent exercise above anaerobic threshold, separated by periods of rest or

low intensity exercise that does not allow for full recovery (10, 38). Repeated bouts at a high
intensity have been shown to improve lipid oxidation, insulin sensitivity, and vascular
endothelial function as well as increased maximal oxygen uptake, and decreased
subcutaneous fat (2, 17).

HIIT encompasses several different exercise protocols that manipulate levels of

intensity, interval duration, recovery times, and total work volume (10, 38). Additionally, it

encompasses various modalities, including running and cycle ergometers. Generally, HIIT

protocols are completed at near maximal intensities (between 80-100%) for longer periods of
time (three-four minutes) (39). Sprint Interval Training (SIT), a type of HIIT, incorporates
all-out supramaximal (>100% %HRmax) sprint intervals (~30 seconds) with relatively long
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periods of active recovery between the intervals (39). The major difference between HIIT

and SIT is in the ‘all-out’ effort expected of the participants. The higher intensity results in
shorter intervals and total duration (10, 37, 38). Both HIIT and SIT have shown rapid,

beneficial adaptations that may improve cardiovascular health and facilitate type 2 diabetes

prevention in both pre-clinical and clinical populations (17). However, to our knowledge, no
studies have evaluated how these changes might affect an individual’s risk of developing

CVD in the next ten years. The purpose of this study was to determine if 16 weeks of R-SIT
and Diabetes Prevention Program (DPP) reduces the 10-year risk of CVD (determined by
Framingham CVD risk calculator), in a sedentary prediabetic women as compared to a
moderate intensity continuous training protocol combined with DPP.
Methods

This study was a 16-week randomized controlled trial. Sedentary prediabetic women

were recruited from a suburban college city in Virginia and randomly divided into two

groups: Running-Sprint Interval Training (R-SIT) or Moderate Intensity Training (MIT).
Sedentary was defined as those who do not participate in at least 30 minutes of physical

activity at 40-50% VO2R at least three times per week. Recruitment included ads in the local

newspaper, bulk emails dispersed to the university, a local TV public service announcement,
fliers posted around the community and physician’s offices, and a Facebook page.

Additionally, all participants attended 16 weeks of Diabetes Prevention Program (DPP)

education with trained lifestyle coaches. Data was collected at baseline, midline, and post
intervention and included: Framingham Risk Score (FRS), Vascular Age (VA), Blood

Pressure (BP), Total Cholesterol (TC), High Density Lipoprotein Cholesterol (HDL-C), Low
Density Lipoprotein Cholesterol (LDL-C), Very Low Density Lipoprotein Cholesterol

(VLDL-C), Triglycerides (TG), body weight, height, and cardiovascular fitness level (VO 2max).
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Participants were all classified as “low” or “moderate” risk according to American

College of Sports Medicine (ACSM) (57). Additionally, they had to be in overall good health
with no previous CVD, pulmonary, or metabolic syndrome diagnosis. Participants were

excluded if they could not perform the activities, were not physician-diagnosed prediabetic,
were not of mental capacity to consent, or were pregnant and/or breastfeeding. This study
was approved by James Madison University’s Institutional Review Board.
Preliminary Meetings

Participants attended two or three preliminary meetings prior to randomization (see

Figure 1). Participants that had physician approval during the familiarization meeting were

able to condense the familiarization and fitness/anthropometric testing meetings into one.

During the familiarization meeting, researchers explained testing and study procedures, and

risks. Participants completed an Informed Consent form and received three day Food Intake
Records (to be completed at home during two weekdays and one weekend day). The

researchers provided participants with detailed verbal and written instructions on how to

accurately collect three day Food Intake Records. A follow-up meeting with the participants
was scheduled for a later date to review recorded food intake data. Records were analyzed

using University of Minnesota Nutrition Data System for Research 2012 (Minneapolis, MN).
Records were reviewed by a different researcher after the initial analyses to ensure accuracy.
Fitness Testing

A physician approval form was required prior to any exercise or fitness testing.

During the fitness and anthropometric meeting, participant’s resting blood pressure (BP),

weight, height, and body composition were recorded. All BP measurements were made via
auscultation. Body composition was collected using a GE Lunar iDEXA (Madison, WI).

Additionally, participants completed a Modified Balke VO 2max test on a Cosmos Treadmill
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(Nussdorf-Traunstein, Germany) using ParvoMedics TrueOne Metabolic System (Sandy,

UT) (57). The Modified Balke protocol was selected based on recommendations by ACSM
for older or deconditioned participants with chronic diseases (57). Heart Rate (HR) was

monitored using Polar Heart Rate Monitor (Oulu, Finland) and recorded every minute after
the third minute. Additionally, BP and Rate of Perceived Exertion (RPE) based on Borg’s
scale were recorded every third minute. Maximal effort was defined as participants having
reached one or all of the following: 19-20 on the RPE scale, Respiratory Exchange Rate

(RER) reached 1.1 and/or the participant was within 10 beats of age-predicted max heart
rate. All testing was repeated at midline and post intervention.
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Figure 1: Timeline of 16-Weeks for R-SIT and MIT Sedentary Prediabetic Participants

Blood Samples

Participants were instructed to fast for 8-10 hours and report to a clinical lab at one

of three Sentara RMH Medical Centers (Harrisonburg, VA) for a blood draw administered
by certified phlebotomists.
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Framingham Risk Score

FRS was calculated using a calculator downloaded from

www.framinghamheartstudy.org (43). The CVD calculator uses age, gender, total cholesterol,
HDL-C, smoking habits, and systolic BP to estimate the risk of developing CVD in the next
10 years of non-diabetics between the ages of 30-74 who have no previous heart disease
diagnosis.

Experimental Intervention

DPP and training interventions lasted 16 weeks. DPP meetings lasted one hour and

all participants were expected to be compliant with the program. Additionally, participants

met three times per week for 34-84 minutes of supervised training per session. Both training
protocols were broken up into four progressing blocks consisting of four weeks per block
(see Table 1). Prior to all exercise resting BP and resting HR were recorded in the seated

position. Participants began each training with a warm-up that consisted of five minutes of

dynamic stretching plus five minutes of walking on the treadmill at a self-selected speed with
no incline (0% grade). Total warm-up time was 10 minutes. Participants ended each session
with a five minute treadmill cool down at a self-selected speed and 0% grade. Immediately
following treadmill cool down, final HR and RPE were recorded. Participants then

completed five minutes of dynamic stretching. Total cool down time was 10 minutes. After
cool down and a brief period of rest, resting BP was measured and recorded. Every four

weeks, training progressed for both groups. In both groups participants were allowed to
exercise at a self-selected incline to reduce orthopedic stress (59).

R-SIT Group: Immediately following warm-up, participants began interval training. An
interval was defined as 30-seconds of all-out sprint at a self-selected speed and grade,
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followed by four minutes of active recovery (walking) at self-selected speed and 0% grade.
Participants received encouragement from the researchers to sprint as fast as possible to

ensure that maximal effort and heart rate was achieved. HR was recorded at the end of each
active recovery and at the end of each sprint. RPE was recorded at the end of each sprint.

Every four weeks the training progressed as follows: weeks 1-4, four intervals; weeks 5-8, six
intervals; weeks 9-12, eight intervals; and weeks 13-16, 10 intervals (Table 1).

MIT Group: Immediately following warm-up, participants began moderate intensity

training at 45-55% Heart Rate Reserve. HR was recorded every five minutes. Every four
weeks the training progressed as follows: weeks 1-4, 30 minutes; weeks 5-8, 40 minutes;
weeks 9-12, 50 minutes; and weeks 13-16, 60 minutes.
Statistical Analysis

All statistical data was analyzed using IBM SPSS 21.0 statistical software package

(Armonk, NY). Data were analyzed via repeated-measures ANOVA. For variables where
Mauchly’s Test of Sphericity had been violated, the Huynh-Feldt correction was applied.

Paired sample and independent sample t-test were then used to compare the relationship of
the variables. Significance level was set a priori at p < 0.05.
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Table 1: Comparison of Training Sessions for R-SIT and MIT Sedentary Prediabetic Women

R-SIT*

MIT*
Warm-Up
5 minutes dynamic stretching
5 minutes treadmill walking

Weeks 1-4: 4 intervals
Weeks 5-8: 6 intervals
Weeks 9-12: 8 intervals
Weeks 13-16: 10 intervals

Weeks 1-4: 30 minutes
Weeks 5-8: 40 minutes
Weeks 9-12: 50 minutes
Weeks 13-16: 60 minutes

Cool Down
5 minutes treadmill walking
5 minutes dynamic stretching
Active Time
(Total Sprint Minutes + Total Recovery
Minutes)
Weeks 1-4: 14 minutes (2+12)
Weeks 5-8: 23 minutes (3+20)
Weeks 9-12: 32 minutes (4+28)
Weeks 13-16: 41 minutes (5+36)

Active Time
Weeks 1-4: 30 minutes
Weeks 5-8: 40 minutes
Weeks 9-12: 50 minutes
Weeks 13-16: 60 minutes

Total Session Time
Weeks 1-4: 34 minutes
Weeks 5-8: 43 minutes
Weeks 9-12: 52 minutes
Weeks 13-16: 61 minutes

Total Session Time
Weeks 1-4: 50 minutes
Weeks 5-8: 60 minutes
Weeks 9-12: 70 minutes
Weeks 13-16: 80 minutes

*Abbreviations: R-SIT (Running Sprint Interval Training); MIT (Moderate Intensity Training)

Results

Thirty-one sedentary, prediabetic men and women were recruited and randomly

assigned to either MIT (n=13) or R-SIT (n= 18) groups. Twenty-four participants completed
midline testing (MIT=10, R-SIT=13) and 16 participants completed the 16-week

intervention (MIT=10, RSIT=6). From baseline to post-testing four dropped due to
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unrelated injuries, two due to medial tibial stress syndrome, two reported ankle and knee
pain, five due time constraints, and two for an unknown reasons. Five male participants

completed the screening and recruiting process. Of the five, only one completed the 16week intervention. As a result, the data presented in this study only includes female

participants. All remaining participants were required to attend at least 40 of the 48 training
sessions to meet the adherence requirement. There were no significant differences in
adherence between the groups (R-SIT: 43.00+3.16, MIT: 43.00+4.09 total sessions).
Baseline Measurements

At baseline, there were no significant differences between groups in age, weight,

BMI, TC, HDL-C, VLDL-C, LDL-C, TG, VO2max, and BP (p<0.05; Table 2). Significant

differences were observed in FRS (R-SIT: 3.45+2.39, MIT: 6.41+2.26%) and Vascular Age
(VA) (R-SIT: 43.33+14.58, MIT: 59.33+9.19 years). There were no significant baseline
differences between groups in any dietary markers. Additionally, there were no dietary
differences between groups at any time point (see Table 3).

Framingham Risk Scores, Vascular Age, Clinical, and Blood Lab Values

There were no significant differences for FRS, VA, clinical, and blood lipid markers.

Nevertheless, there was a trend towards significance for several variables (see tables 4 and 5).
There were observed between-group differences (R-SIT, MIT respectively) at

midline in TC (168.83+19.47, 216.56+58.85 mg/dL), FRS (2.90+2.10, 6.41+2.34%), and VA
(39.83+14.03, 59.00+10.26 years). There were between group differences at 16-weeks in TC
(167.17+19.89, 218.89+55.13 mg/dL), VLDL (18.67+4.97, 30.55+8.5 mg/dL), TG

(101.33+25.44, 152.56+42.90 mg/dL), FRS (2.73+1.59, 6.74+2.90%), and VA (39.50+11.18,
60.56+11.38 yo). Lastly, R-SIT significantly changed from midline to post in TG (-23.33 +
17.92 mg/dL) and DBP (6.33 + 5.85 mm/Hg).
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Anthropometric and Fitness

There was a significant time by group interaction in weight, BMI, and BF%.

Additionally, there was a statistically significant effect of time on weight, BMI, and body fat
percent (BF%).

A significant decrease in BMI from baseline to mid (-0.63+0.60 kg/m 2) and a trend

towards a significant decrease (p=0.078) from baseline to post (-0.85+0.94 kg/m 2) in the RSIT group were observed. There were also significant decreases in BF% from baseline to
mid (-2.33+0.72%), however, there was a significant increase from mid to post

(+1.53+0.46%) in this group. Lastly, the increase in lean body mass from mid to post

(+1.05+0.46 kg) in R-SIT was trending towards significance (p=0.059). Though there was
not a main effect of time within R-SIT for VO2max, a significant increase from baseline to
post (+1.86+1.011 mL kg-1min-1) occurred.

Alternatively, t-test results for MIT indicated a significant decreased in both weight

and BMI from baseline to mid (-3.76+1.63 kg, -1.36+0.85 kg/m 2, respectively), mid to post
(-1.95+2.36 kg, -1.07+0.95 kg/m2), and from baseline to post (-5.71+3.61 kg, -2.42+1.40
kg/m2). BF% decreased from baseline to mid (-0.90+1.21%) with trending significance

(p=0.074) and significantly decreased from baseline to post (-1.58+1.54%). Lastly, there was

a trend to significance (p=.083) in lean body mass of MIT from baseline to post (-1.14+1.72
kg).
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Table 2: Baseline Characteristics for R-SIT€ and MIT€ Sedentary Prediabetic Women
Age (years)
Weight (kg)
BMI (kg/m2)
Body Fat (%)
Lean Body Mass (lbs)
Total Cholesterol (mg/dL)
HDL-C (mg/dL)
VLDL-C (mg/dL)
LDL-C (mg/dL)
Triglycerides (mg/dL)
Framingham (%)
Vascular Age (years)
VO2max (mL kg-1min-1)
RHR (bpm)
SBP (mm Hg)
DBP (mm Hg)

All Participants
(n=15)
47.80+15.67
107.83+31.11
40.51+10.78
57.36+5.32
109.16+22.53
199.73+45.91
59.47+20.30
25.93+10.76
113.73+33.06
148.33+50.03
5.23+2.69*
52.93+13.79*
21.45+3.97
75.87+9.75
131.07+14.96
82.53+12.06

R-SIT (n=6)

39.17+20.52
112.01+28.93
40.65+9.15
49.74+4.13
104.37+25.96
179.83+10.50
52.50+18.12
20.67+12.61
106.67+14.83
124.17+59.64
3.45+2.39
43.33+14.58
22.40+3.03
77.33+12.24
127.33+11.29
83.33+13.84

MIT (n=9)

53.56+8.56
105.04+33.89
40.41+12.29
50.71+6.10
107.17+23.52
213.00+55.89
64.11+21.34
29.44+8.28
118.44+41.39
164.44+37.79
6.41+2.26
59.33+9.19
20.81+4.54
74.89+8.36
133.56+17.17
82.00+11.58

Data are presented as mean+SD, *Significant difference between groups at baseline (p<0.05)
€
R-SIT: Running Sprint Interval Training; MIT: Moderate Intensity Training
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Table 3: Dietary Markers at Baseline, Midline, and Post 16-Week Intervention for R-SIT € and MIT€
Sedentary Prediabetic Women
Calories (kcals)
baseline
midline
post
Carbohydrates
(%)
baseline
midline
post
Fat (%)
baseline
midline
post
Protein (%)
baseline
midline
post
Saturated Fat (g)
baseline
midline
post

All Participants
(n=15)

R-SIT (n=6)

MIT
(n=9)

2246.87+828.72 2697.33+740.05 1946.56+778.41
1797.40+408.34¥ 1819.17+123.49¥ 1782.89+530.73
1774.67+533.42¥ 1806.67+451.60¥ 1753.33+607.62
43.58+9.90
47.49+12.86
47.91+13.91

45.00+7.54
50.86+3.09
51.99+8.12

42.64+11.55
45.23+16.41
45.18+16.63

40.28+7.66
34.74+12.29¥
33.09+8.40¥

37.73+4.56
30.45+4.23¥
31.37+5.87

41.99+9.02
37.60+15.17
34.24+9.91¥

14.43+2.63
16.76+3.17¥
20.35+9.14¥

15.22+2.43
17.50+2.55¥
16.80+3.43

13.91+2.76
16.26+3.60
22.71+11.10¥

36.32+12.02
24.72+11.03¥
22.86+11.72¥

38.51+10.16
20.69+3.63¥
21.73+6.62¥

34.85+13.51
27.40+13.58
23.61+14.53¥

Data are presented as mean+SD, *Significant difference between groups at given time
point (p<0.05), ¥Significant difference within group from baseline (p<0.05), αSignificant
difference within group from midline (p<0.05)
€
R-SIT: Running Sprint Interval Training; MIT: Moderate Intensity Training
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Table 4: Framingham Risk Scores, Vascular Age, and Input Variables that Effect Framingham Risk
Score at Baseline, Midline, and Post 16-Week Intervention for R-SIT € and MIT€ Sedentary Prediabetic
Women
Age (years)
baseline
Framingham Risk Score (%)
baseline
midline
post
Vascular Age (years)
baseline
midline
post
Cholesterol (mg/dL)
baseline
midline
post
HDL-C (mg/dL)
baseline
midline
post
SBP (mm/Hg)
baseline
midline
post

All Participants (n=15)

R-SIT (n=6)

MIT (n=9)

47.80+15.67

39.17+20.52

53.56+8.56

5.23+2.69
5.01+2.82
5.14+3.14

3.45+2.39*
2.90+2.14*
2.73+1.60*

6.41+2.26*
6.41+2.34*
6.74+2.90*

52.93+13.79
51.33+15.00
52.13+15.25

43.33+14.58*
39.83+14.03*
39.50+11.18*

59.33+9.19*
59.00+10.26*
60.56+11.38*

199.73+45.91+
197.47+51.96+
198.20+50.65+

179.83+10.50
168.83+19.47*
167.17+19.89*

213.00+55.89
216.56+58.85*
218.89+55.13*

59.47+20.30ω
56.53+17.15ω
55.13+19.95¥ω

52.50+18.12
48.33+13.25
49.33+16.28

64.11+21.34
62.00+17.92
59.00+22.11

131.07+14.96
126.00+14.56
126.93+12.58

127.33+11.29
120.67+15.88
122.67+13.72

133.56+17.17
129.56+13.33
129.78+11.68

Data are presented as mean+SD, *Significant difference between groups at given time point (p<0.05),
¥Significant difference within group from baseline (p<0.05), αSignificant difference within group from midline
(p<0.05). ωTrending towards significant effect of time (p<0.08). +Trending towards significant time x group
interaction (p<0.08). €R-SIT: Running Sprint Interval Training; MIT: Moderate Intensity Training
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Table 5: Blood Lipid Variables Related Cardiovascular Disease at Baseline, Midline, and Post 16-Week
Intervention for R-SIT€ and MIT€ Sedentary Prediabetic Women
VLDL-C (mg/dL)
baseline
midline
post
LDL-C (mg/dL)
baseline
midline
post
TG (mg/dL)
baseline
midline
post

All Participants (n=15)

R-SIT (n=6)

MIT (n=9)

25.93+10.76
27.49+8.23
25.80+9.31

20.67+12.61
23.00+7.38
18.67+4.97*

29.44+8.28
30.49+7.70
30.56+8.52*

113.73+33.06+
113.04+39.27+
117.07+38.27+

106.67+14.83
96.50+18.61
97.83+23.61

118.44+41.39
124.07+46.27
129.89+41.86

148.33+50.03
140.93+37.92
132.07+44.25

124.17+59.64
124.67+32.81
101.33+25.44* α

164.44+37.79
151.78+38.90
152.56+42.90*

Data are presented as mean+SD, *Significant difference between groups at given time point (p<0.05),
¥Significant difference within group from baseline (p<0.05), αSignificant difference within group from midline
(p<0.05). ωTrending towards significant effect of time (p<0.08). +Trending towards significant time x group
interaction (p<0.08).€R-SIT: Running Sprint Interval Training; MIT: Moderate Intensity Training
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Table 6: Anthropometric and Fitness Measures at Baseline, Midline, and Post 16-Week Intervention for
R-SIT€ and MIT€ Sedentary Prediabetic Women
Weight (kg)
baseline
midline
post
BMI (kg/m2)
baseline
midline
post
Body Fat (%)
baseline
midline
post
Lean Body Mass (kg)
baseline
midline
post
VO2max (mLkg-1min-1)
baseline
midline
post

All Participants
(n=15)

R-SIT (n=6)

MIT
(n=9)

107.83+31.11
105.16+31.04¥
103.73+30.04 α ¥

112.02+28.93
110.98+29.74
110.33+30.05

105.04+33.89
101.28+33.03¥
99.33+30.99 α ¥

40.51+10.78
39.44+10.72¥
38.71+10.22 α ¥

40.65+9.15
40.02+9.17¥
39.80+9.21

40.41+12.29
39.06+12.17¥
37.99+11.32 α ¥

50.36+5.32
48.69+6.47¥
48.45+6.10¥

49.74+4.13
46.03+3.95*¥
47.43+5.13α

50.71+6.10
49.69+7.16*
49.13+6.88¥

49.62+10.24
48.69+10.30
50.66+10.92

51.24+10.34
47.44+11.80
55.29+11.47

48.71+10.69
49.19+12.69
47.58+9.97

21.45+3.97
22.44+4.58
22.32+6.37

22.40+3.03
23.50+1.95
24.54+2.81¥

20.81+4.54
21.83+5.64
22.84+5.82

Data are presented as mean+SD, *Significant difference between groups at given time point (p<0.05),
¥Significant difference within group from baseline (p<0.05), αSignificant difference within group from midline
(p<0.05). €R-SIT: Running Sprint Interval Training; MIT: Moderate Intensity Training

Discussion

For the purposes of this study, baseline, midline, and post scores of participants’ risk

of developing CVD in the next 10 years were determined and analyzed. The CVD risk

calculator uses age, gender, total cholesterol, HDL-C, smoking habits, and systolic BP to

estimate the risk of non-diabetics between the ages of 30-74 who have no previous heart

disease diagnosis. Since there were no significant within-group changes in any of the input
variables used to calculate FRS and VA, there were no significant changes in these scores
(see table 4). The differences observed between groups is likely the result of increases by
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MIT from midline to post. Additionally, global high risk is considered >20% FRS, and both

groups mean baseline were both below high risk and considered low risk (R-SIT: 3.45+2.39,
MIT: 6.41+2.26%). As a result, more research is needed to determine if an individual with a
high starting FRS may benefit from an R-SIT or MIT protocol.

The secondary findings of this study were that after 16-weeks of exercise training,

MIT had significant within group decreases for weight, BMI, and BF%, while R-SIT

significantly decreased in BF% and significantly increased VO 2max (mLkg-1min-1). There was

also a trend towards significance for BMI within R-SIT (p=.078) (see Figure 2). Additionally,
R-SIT participants had significant changes in TGs from midline to post. Though FRS and
VA were significantly different between groups at all three time points, there were no

significant within-group changes observed. Participants attended weekly DPP classes and

were expected to improve dietary intake during the 16 weeks. Since there were no between
group differences in dietary markers, it can be expected that both groups experienced the
same changes, suggesting that diet did not have a different impact on the results of either
group.

Changes observed for weight and BMI are typical, so the findings here are consistent

with the present literature (2, 16). A prior study using a running training protocol in clinical

participants revealed that after 16 weeks of running-HIIT (R-HIIT), weight was reduced by
three and four percent by the R-HIIT and moderate intensity groups, respectively (16).
Likewise, BMI was significantly reduced in both groups with no significant differences

between the groups. It should be noted, however, that the purpose of that study was to

compare the modes independent of the time; thus training volumes were equalized to similar
amounts of kilocalories per session so that R-HIIT exercised for 40 minutes while the
moderate intensity group exercised for 47 minutes.
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Similarly, after 12 weeks of R-HIIT, Tan et al. found that BMI, was significantly

reduced in both R-HIIT and moderate intensity group, with no significant differences

between groups, in overweight college age women (2). Most notably, there was a 9.9% body

fat loss in the R-HIIT group, which was significantly more when compared to a 5.2% loss in
the moderate intensity group. The researchers concluded that R-HIIT would be more

beneficial than moderate intensity exercise in an overweight population, as a result of the

decrease in fat tissue accumulation (2). It is important to mention that during the 12 weeks
participants of this study exercised five times per week on an outdoor track as opposed to

the typical three times on a treadmill seen in most R-HIIT and R-SIT studies, which could

account for some of the findings. Results of the present study also noted changes in BF% in

line with the findings of Tan et al. Both R-SIT and MIT significantly decreased BF% (R-SIT:
-2.16+2.53%, MIT: -1.57+1.54%). The changes from baseline to post were significant for
MIT, however, there was only significance from baseline to midline

(-2.33+0.72%) and midline to post (+1.53+0.46%) for R-SIT. Though there was an overall
decrease in BF% in R-SIT from baseline to post, it was likely not significant because of the

increase from midline to post. The groups were only significantly different from each other
at midline.

Metabolically, exercise induces increases in epinephrine, norepinephrine, and growth

hormone resulting in hormone-stimulated lipolysis. This leads to an increase in fatty acid

availability and thus an increase in fatty acid uptake and oxidation for energy (13, 16). Acute
bouts of HIIT appear to significantly increase these hormones, and since visceral fat is

particularly sensitive to these hormones, it has been suggested that HIIT may be an effective
method in improving body composition and reducing visceral fat (13). The impact of lipid
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oxidation on clinical populations and its relationship to intensity still needs further
investigation (2).

Results of current SIT and HIIT studies are mixed in regards to changes in blood

lipid profiles, and the exact impact of interval training has yet to be defined. This could be a
result of differing methodology, though the main reasons are likely short intervention time
(24) and/or healthy participants with normal blood lipid profiles at baseline (8, 22, 25).

Additionally, timing of meals and diet may exacerbate these discrepancies (26). Regardless,
interval studies that incorporate blood lipid profiles are limited.

The present study observed significant decreases in TG from midline to post testing

in R-SIT participants. There were no significant changes in other blood lipid markers for

either R-SIT or MIT. However, there was a significant change in HDL-C for the group as a

whole from baseline to post. Typically a decrease in saturated fat consumption will positively
impact lipid values, yet, participants of the present study decreased HDL-C. There is

evidence to suggest that the decrease in HDL-C may be due to a decrease in saturated fat

coupled with a corresponding increase in carbohydrate (60, 61). Lastly, there were between
group differences at post testing for total cholesterol and VLDL. This between group

differences are likely the result of increases in both cholesterol and VLDL for MIT from
baseline to post testing.

A proposed mechanism for a decrease in TG concentrations may be a result of TG

clearance in the skeletal muscle and a decreased hepatic production of very-low-density

lipoproteins (VLDL-C) (11). Though changes in TG concentrations are acute and likely
associated to the energy expenditure, repeated bouts of exercise often lead to a more
favorable blood lipid profile (12).
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To our knowledge our present study is the first to closely investigate the effects of

two exercise protocol on the 10-year risk of developing CVD in prediabetic women.

Specifically, we are the first study to investigate FRS and VA as it relates to interval training
in a clinical population. There are limitations of the present research that should be taken

into consideration. The first major limitation is while participants were diagnosed prediabetic
and as a result at higher risk for CVD (19, 45), the average baseline FRS scores were within a
normal range, suggesting that any improvement would have been minimal and not

significant. To fully understand the effects that interval training might have on FRS, more

research should be done in individuals with higher baseline scores. Another major limitation
was related to individuals with prescribed hypertension medication (prior to beginning the
study). While the Framingham calculator accounts for hypertension control, it is not

sensitive to incremental changes to the medication dosage. As the training progressed, there
were some participants that reduced their dose without completely discontinuing the

medication. The change in medication might suggest that the exercise was helping control

BP, however, the FRS calculator cannot account for this reduction in dose and still classified
the participants as higher than normal risk. Additionally, changes to these medications may
have had an initial and potentially adverse effect on BP while the body adjusted to the
change.

The present study had challenges with high drop-out rates, specifically within the R-

SIT intervention group. Of the 12 R-SIT drop-outs, four had injuries that may have been

related to the exercise intervention (3 females, 1 male). The physical strain of this exercise

was often verbalized to researchers by the remaining R-SIT participants. Alternatively, there

were no injury related drop-outs in MIT. This suggests that R-SIT may be too strenuous for
an overweight/obese population. Additionally, the average age of the R-SIT participants
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with an injury related drop-out was 52 + 10.90 years old. The average age R-SIT participants
that completed was 39.17 + 20.52. If the injury-drop out ages are included, the average age

increases to 44.40 + 17.86 years. This may also suggest that this type of strenuous exercise
may not be appropriate for an older population. Research with a more appropriate mode

that reduces orthopedic stress, such as elliptical or cycle ergometer should be considered,

especially for an older population. Additionally, an introductory period for participants to get
accustomed to the equipment and exercise may also reduce injury related drop-outs.

Other limitations included food record discrepancies. It is well documented that

individuals often underreport intake (26). Discrepancies between reported and actual diet

may have provided further evidence to some of the changes. Additionally, the small sample
size may have also limited the results observed in this study. Lastly, holidays and seasonal
changes were a limitation to this study. As the weather got colder, participants may have

been less likely to spend time outside, which could have resulted in an average reduction of
unstructured activity (55). Also, seasonal holidays that occurred during the 16-week span

(Thanksgiving to New Year’s) may have negatively impacted participants’ body weight, body
fat percent, BP, and dietary intake (56).

In conclusion, though previous R-SIT and HIIT studies have suggested improved

body composition and cardiovascular risk factors when compared to MIT, the present study
only observed significant changes in body composition and minimal changes to CVD risk

factors. Additional research is needed to further understand the effects of run sprint interval
training on blood lipid profiles and its relationship with CVD, especially in the clinical
population.
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Figure 2: Average Framingham Risk Score (%), Vascular Age (years), Body Mass Index (kg/m2), Total Cholesterol (mg/dL), Triglycerides (mg/dL), VLDL-C (mg/dL) of all participants,
R-SIT, and MIT groups at baseline, midline and post intervention during the 16-week study. *Significant difference between groups at given time point (p<0.05), ¥Significant

difference within group from baseline (p<0.05), αSignificant difference within group from midline (p<0.05)
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Appendices
Appendix A: General CVD Risk Prediction Calculator

(Downloaded from https://www.framinghamheartstudy.org/risk-functions/cardiovasculardisease/10-year-risk.php# on June 23, 2014)
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Appendix B: Informed Consent
James Madison University
Departments of Kinesiology and Health Sciences
Consent for Investigative Procedure
(Informed Consent)

You are being asked to participate in a research study conducted by Drs. Elizabeth Edwards, Jeremy
Akers, Trent Hargens, David Wenos, and graduate students Katie Hilovsky, Jo Mandelson, and
Nicole Gilbertson from the Departments of Kinesiology and Health Sciences at James Madison
University. The purpose of this study is to determine the effect of low volume, high intensity training
on physical fitness, physical activity enjoyment, and physical activity adherence, along with factors
known to increase risk for chronic disease (blood lipids, etc.) by conducting an experimental study in
a cohort of prediabetic men and women.
Research Procedures. The study will consist of a 16-week supervised exercise program. The
research study will consist of three groups. Each participant will be randomized to a control, low
volume, high intensity training, or moderate intensity training group. Prior to beginning the study, at
the mid-point of the study (8 weeks), upon completion of the study (16 weeks), and at three-month
and six-month follow-up, you will complete various supervised tests and questionnaires to measure
the physical fitness, health status, lifestyle behaviors, body composition, blood lipids, insulin, and
blood glucose levels.

Note: In the event you discover that any of the following information is not clear, please ask
one of the researchers to explain immediately.
Blood Pressure. Blood pressure measurements will be taken using a sphygmomanometer and
stethoscope. A blood pressure cuff will be placed over the upper portion of your right arm, slightly
above the elbow. The cuff will be inflated to approximately 200mmHg and then slowly released,
while a researcher uses a stethoscope to listen to sounds of blood flow through the vein on this
inside of your elbow.

Blood Draws. A fasted (8-10 hour) blood sample will be obtained by a butterfly needle in a vein in
your mid arm. All blood draws will be taken from Sentara Rockingham Memorial Hospital (SRMH).
In order to minimize the transfer of blood-borne pathogens, the trained person taking your blood
will wear latex gloves at all times during blood sampling and testing. All values will be sent to
researchers in a sealed envelope. Per SRMH protocol you will be required to provide a medical
provider’s information at each blood draw session. If blood values are outside normal/optimal
ranges the blood values will be sent to your primary medical provider. For each blood draw, we will
be measuring several different substances in the blood related to health and disease risk.
Preparation for Blood Draw. You will be asked to fast for 8-10 hours before the session. This
includes coffee, tea, alcohol, or tobacco products.

Body Composition and Bone Mineral Density. Your height and weight will be measured and
used to calculate body mass index BMI (kg/m2). Additionally, the size of your waist and hips will be
measured with a cloth tape measure. Your waist measurement is important in determining your risk
for cardiovascular disease and diabetes. Dual-energy x-ray absorptiometry (DXA) will be used to
estimate body composition data and bone mineral density through the whole body scan. For the
DXA scan, you’ll be asked to lie on your back and remain still for the whole scan; the scan will last
approximately 6-10 minutes.
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Maximal Exercise Test. The purpose of the maximal graded exercise test, also known as the
VO2max test, is to measure cardiorespiratory fitness. Cardiorespiratory fitness is the ability to engage
in dynamic moderate- to high-intensity exercise for a prolonged period of time. Cardiorespiratory
fitness is an important consideration when health risks and overall exercise capability are assessed.
High levels of cardiorespiratory fitness are correlated with reduced risk coronary artery disease.
Preparation for Exercise Testing. Prior to exercise testing, we will ask you to not eat or drink
anything, except water for three hours prior to the test. Please note that this includes caffeinated
beverages – such as coffee or tea! Use of tobacco products should be avoided at least three hours
prior to testing as well. Please avoid heavy exercise on the testing day. Try to get to get at least six
hours of sleep the night before, to ensure that you are well rested. Wear clothing that is comfortable
and allows you to move freely, such as shorts, a t-shirt, and comfortable running shoes. Be aware
that the test is fatiguing, so you may wish to be fully hydrated before the test.

Procedure for Exercise Testing. Resting heart rate and blood pressure will be taken prior to
testing. The treadmill test follows a predetermined protocol to obtain a maximal oxygen uptake.
You will run on a treadmill, with the speed and/or grade increasing as the test progresses, until you’re
working as hard as you can. You will be fitted with a heart rate monitor chest strap and a pulmonary
facemask. Nonverbal cues will be used to communicate during the test. Hand signals include “yes,”
“no,” and/or “stop the test.” It is important to realize that you may stop the test when you wish
because of feelings of fatigue or any other discomfort. Additionally, we may stop the test at any time
due to signs of fatigue or abnormal physiological responses. These may include failure for heart rate
increase with increased workload, dizziness, chest pains, or muscular fatigue. Please note that both
protocols and procedures are in adherence with the guidelines set forth by the American College of
Sports Medicine for exercise testing.
You will be permitted to leave once post exercise heart rate drops below 100 beats per minute or
resting heart rate levels. Avoid a hot shower and a heavy meal for at least an hour after the exercise
test.

At-Home Sleep Assessment: The at-home sleep assessment will be utilized to screen for possible
obstructive sleep apnea (OSA), a frequent co-morbid condition with diabetes, and a condition that
may confound data analysis without accounting for. Research staff will instruct the you on the proper
setup and use of the ApneaLink™ at-home screening device. The ApneaLink device is composed of
a pulse oximeter, which is worn on the end of an index finger, and a nasal cannula, which is worn
over the face, and into the nose to measure airflow. The ApneaLink device is harmless and painless
to wear. You will be wearing this device one night while you sleep only at the beginning of the study.
Heart rate variability (HRV): HRV will be utilized to assess autonomic function, which is another
proposed mechanism linking obstructive sleep apnea and cardio vascular disease. You will be
asked to complete a resting HRV and heart rate measurement using a monitor that is strapped on
your chest. You will be asked to lie flat on your back in a darkened room, while heart rate and HRV
are measured over a 15 minute time period. You will be asked to breathe in rhythm with an
instrument that is set at 12 beats per minute, thus representing 12 breaths per minute which is
considered to be the average respiration rate for a healthy adult.
Health Status. Your health status will be determined via questionnaires and ACSM’s Risk
Stratification for Cardiovascular Disease Risk (ACSM, 2010). Assessment of your risk for
cardiovascular disease will be made using the ACSM’s Coronary Artery Disease Risk Factor
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Thresholds along with the ACSM Risk Stratification. Risk stratification is based upon age, family
history, smoking habits, blood lipid levels, and fasted blood glucose values, resting blood pressure,
body mass index and physical activity habits. We will also be asking about current and previous
conditions, surgeries, and medications, so that we may ensure that you are healthy enough to
participate in this study.

Lifestyle Behaviors
You will be asked to complete the following questionnaires:
a. Exercise Behavior – The International Physical Activity Questionnaire (IPAQ) estimates how much
activity you have participated in over the previous seven days. It will ask about your physical activity
as part of your daily life, including work, as well as leisure time activity.
b. Perceived Enjoyment– The Physical Activity Enjoyment Scale (PACES) asks you about your
perceptions and feelings about physical activity.
c. Dietary Behavior –A 3-day dietary record, where you will record what you consumed for 3
nonconsecutive days.

d. Sleepiness- The Epworth Sleepiness Scale is a measure of a person’s general level of daytime
sleepiness, or their average sleep propensity in daily life.

f. Health Related Quality of Life- The Health Related Quality of Life Scale is a measure of a person’s
physical and mental health and function.

Time Required. If you are randomized to the training group then you will be asked to commit to up
to three hours per week, for sixteen weeks for the training segment of this project. Additionally, you
will be asked to commit to ten testing and informational sessions that will each last up to two hours.
Testing and training will take place as follows:
●

●

●
●

Familiarization Session (Pre): This is the familiarization session. During this session, all tests
and procedures will be explained, after which we’ll ask you to complete the appropriate health
and medical status questionnaires and an Informed Consent Form. Additionally, participants
will be asked to complete the questionnaires pertaining physical activity levels, health behavior,
sleepiness, and perceived enjoyment. This session is estimated to last approximately 1 ½ -2
hours. You will also be given dietary record forms to be completed and returned to the
researchers at the next meeting. After this session, future questionnaires will be completed
during the clinical testing sessions.
Clinical Testing (Pre, Mid, Post, 3M FU, 6M FU): In this session we measure your blood
pressure and heart rate and complete a dual x-ray absorptiometry (DXA) scan for the assessment
of body composition and bone mineral (hip) density. Diet records will also be collected. This
session is estimated to last approximately 1 ½ -2 hours: 1 ½ hours for testing, 20 minutes for
dietary records. All clinical testing will take place in the Kinesiology Human Performance Lab.
For the mid-point, post-training, follow-up sessions, you will also be asked to complete the study
questionnaires at this session. This is expected to add approximately 15 minutes to the session.
Fitness Testing (Pre, Mid, Post, 3M FU, 6M FU): You will be asked to come to complete a
maximal exercise test (VO2max test) the same day as your clinical testing. Maximal testing will be
completed in the Kinesiology Human Performance Lab.
Blood Values (Pre, Mid, Post, 3M FU, 6M FU): In this session you will be asked to visit the
Sentara RMH Outpatient Center located with the Sentara RMH Occupational Health Center at
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●

1790-64B to have blood taken. Researchers will provide all documentation for you to take to
each session. You will be required to fast for 8-10 hours. Please note that per SRMH protocol
you will be required to provide a medical provider’s information at each blood draw session. If
blood values are outside normal/optimal ranges the blood values will be sent to your primary
medical provider. This session should last 15 minutes.
Training Protocol: As the main portion of the study, you will participate in a training session 3
days per week that will progress from 30 minutes per session, to 60 minutes per session for the
next 16 weeks. Your group assignment will determine exactly what these exercise sessions will
consist of. In brief, you will either be participating in moderate-intensity training, which consists
of a continuous bout of exercise performed at a moderate intensity (moderate intensity is
described as a 5 or 6 on a scale of 1 to 10); short high-intensity interval training, which consists
of short bouts (30 seconds) of maximal effort exercise followed by longer recovery periods (4
minutes); or a combination of the two, which consists of one day of the continuous moderate
intensity training session and two days of the high intensity interval training. You will be asked
to come into the Marilyn Crawford Fitness Center (Godwin Hall) to complete all training
sessions. Training groups are expected to see improvements in fitness.

Risks. There is minimal risk associated with submaximal exercise testing in individuals who are
“low” or “moderate” risk according to guidelines established by the American College of Sports
Medicine. There is a minimal level of discomfort that may be experienced during the exercise testing,
which includes muscle soreness and fatigue. Muscle soreness may be felt 24-48 hours following the
testing.
The risks of venipuncture blood sampling include possible mild bruising and the risk of transfer of
blood-borne pathogens. This risk is considered to be minimal and all safety precautions for handing
blood samples will be followed according to OSHA protocols and SRMH.

According to the manufacture’s specifications (i.e., GE Healthcare), whole body DXA analysis
exposes participants to 1.5 mrem of radiation. The exposure to radiation during a single chest x-ray
(i.e., 5 mrem) is more than 3 times greater than radiation from DXA. Also, background radiation
from DXA is about equal to the amount of radiation one experiences during a flight from New York
to London. Please note that the effects of the DXA scan are cumulative depending on your prior
exposure to radiation. If you have questions regarding your risk from the scan please consult with the
researchers.
Benefits. Potential benefits from participation in this study include free testing of cardiorespiratory
fitness, body composition, lipid profile, and bone mineral density. You will receive the results from
your individual tests, including a rating of how you compare to individuals within your age category.
Along with these results, you’ll receive information regarding the importance and meaning of
measure, as well as what steps you could take to improve these measures if you would like to. You
will also have the opportunity to learn about habitual dietary intake and your percentages of energy
nutrients and total caloric intake. Participation in this study will also help researchers understand
metabolic responses and adherence to long-term exercise. Finally, if you complete the study, you’ll
receive a free dietary consultation.

If you are randomized to the two training groups you will also receive free monitored workout
sessions and motivation from the researchers. The researchers expect to see positive metabolic
changes for participants in all training protocols that may result in improved health and general wellbeing.
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Confidentiality. All data and results will be kept confidential. You will be assigned an identification
code. All of your questionnaires and other results will be filed only according to your identification
code, with your full name not located in that file. For the duration of the study, your first name will
be stored with this data, so that research staff may address you, but this will be removed at the
completion of the study. These results will be stored in a locked cabinet in a locked office.
Electronic copies of the data will be password protected and kept only on secure servers. Only
research personnel, who may include students, will have access to this data in either hard or
electronic format. Any forms that link your name with your identification number, including this
form, will be kept in a different file, which will be located in the office of one of the head researchers
on this study. Additionally, any electronic formats of this information will be kept by one of the
head researchers and will be password protected with a different password than the data. None of
your test results or data will be located in this file. Access to these files will be limited to the head
researchers on this staff and will only be used for the purposes of matching up your data to previous
results and to contact you for the follow-up measures. After the second follow-up measure, any
form that links your name to your identification number will be destroyed. The data collected will be
analyzed and used to complete three graduate student research theses, a national presentation, and
submission for publication in a professional journal.

Participation and Withdrawal. Your participation is entirely voluntary. You are free to choose not
to participate. Should you choose to participate, you can withdraw at any time without consequences
of any kind. If at any time you choose to withdraw from the study, any identifying information that
links your name to your data will be destroyed at that time.
Reporting Procedures. You will be provided health and fitness tests data at the completion of each
test and will receive the results of your blood tests after they have been processed. The findings of
the study will be presented at regional and national organizations conferences and submitted for
publication in professional journals.

Questions about the Study. If you have questions or concerns during the time of your participation
in this study, or after its completion or you would like to receive a copy of the final aggregate results
of this study, please contact:
Dr. Elizabeth Skidmore Edwards
Department of Kinesiology
James Madison University
edwardes@jmu.edu
540-568-5220

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
Dr. Stewart Pollock,
Chair, Institutional Review Board
Sentara RMH Medical Center
(504) 689-1000
SGPOLLO3@sentara.com

Dr. Jeremy D. Akers, PhD
Department of health Sciences
James Madison University
akersjd@jmu.edu
540-568-8974
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Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this
study. I freely consent to participate. I have been given satisfactory answers to my questions. The
investigator provided me with a copy of this form. I certify that I am at least 18 years of age.
____________________________________
Name of Participant (Printed)

______________________________________
Name of Participant (Signed)

______________
Date

______________________________________
Name of Researcher (Signed)

______________
Date

____________________________________
Name of Researcher (Printed)

Demographic Information
Full Name:

Nickname:

ID# ___________________ (Research personnel use)
Address:
Preferred phone:
________

__________________________
______ Is this your: ☐ Work ☐ Home

Email address: ____________________________
(Month/ Day/ Year)

☐ Cell

☐ Other:

Date of Birth:

Optional Additional Consent
I understand that new risk factors are constantly emerging and that further analysis of my blood
samples, beyond those tests outlined in this consent form may provide valuable information. I
consent to having my blood samples stored indefinitely, so that they may be used in future analyses.
If my blood is used in these tests and yields information that would be pertinent to my health, the
research team will attempt to contact me to give me these results.
______________________________________
Name of Participant (Printed)
______________________________________
Name of Participant (Signed)

______________
Date

______________________________________
Name of Researcher (Signed)

______________
Date

____________________________________
Name of Researcher (Printed)

58
Appendix C: Physical Activity Readiness Questionnaire (PAR-Q)
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Appendix D: Health Status Questionnaire
Health Status Questionnaire
Part I Medical History

1. Has anyone in your family had a heart attack, heart surgery, or sudden death due to cardiovascular disease
prior to the age of 65? (Circle one) Yes
No
If yes, who? _________________
How old were they? (Circle one)

54 or younger

2. Date of last medical exam: ________________

55-59

60-64

Last physical fitness test: _______________

3. Please list any operations that you have had:
_____________________________________________________________________
______________________________________________________________________________________
______________________
______________________________________________________________________________________
______________________
4. Please list any condition for which you have been diagnosed or are being treated for by a physician or health
professional:
______________________________________________________________________________________
______________________
______________________________________________________________________________________
______________________
5. Please list all medications taken in the last six months:
_____________________________________________________________
______________________________________________________________________________________
_____________________
______________________________________________________________________________________
_____________________
6. The occurrence of any of these health symptoms frequently is the basis for medical attention. Please check
how often you have each of the following:
Symptom
Cough up blood
Abdominal pain
Low back pain
Leg pain
Arm or shoulder pain

1
Rarely

2
Infrequently

3
Sometimes

4
Fairly Often

5
Very Often

60
Chest pain
Swollen joints
Feel faint
Dizziness
Breathless on slight exertion
7. Do you smoke? (Circle one)

Yes

No

If yes, how many per day: Cigarettes:
40 or more
20-39
1-9
Cigars or pipes only:
5 or more or any inhaled

10-19

less than 5, none inhaled

Adapted from: Howley and Franks. (1992). Health Fitness Instructor’s Handbook. Health Status Questionnaire.
Champaign :Human Kinetics.
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Appendix E: International Physical Activity Questionnaire (IPAQ)
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
LONG FORM: LAST 7 DAYS SELF-ADMINISTERED FORMAT

FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years)

The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 questionnaires. Long
(5 activity domains asked independently) and short (4 generic items) versions for use by either
telephone or self-administered methods are available. The purpose of the questionnaires is to provide
common instruments that can be used to obtain internationally comparable data on health–related
physical activity.
Background on IPAQ
The development of an international measure for physical activity commenced in Geneva in 1998
and was followed by extensive reliability and validity testing undertaken across 12 countries (14 sites)
during 2000. The final results suggest that these measures have acceptable measurement properties
for use in many settings and in different languages, and are suitable for national population-based
prevalence studies of participation in physical activity.
Using IPAQ

Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is
recommended that no changes be made to the order or wording of the questions as this will affect
the psychometric properties of the instruments.
Translation from English and Cultural Adaptation

Translation from English is encouraged to facilitate worldwide use of IPAQ. Information on the
availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If a new translation is
undertaken we highly recommend using the prescribed back translation methods available on the
IPAQ website. If possible please consider making your translated version of IPAQ available to
others by contributing it to the IPAQ website. Further details on translation and cultural adaptation
can be downloaded from the website.
Further Developments of IPAQ

International collaboration on IPAQ is on-going and an International Physical Activity
Prevalence Study is in progress. For further information see the IPAQ website.
More Information

More detailed information on the IPAQ process and the research methods used in the development
of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000). Assessment of Physical
Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Other
scientific publications and presentations on the use of IPAQ are summarized on the website.
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
We are interested in finding out about the kinds of physical activities that people do as part of their
everyday lives. The questions will ask you about the time you spent being physically active in the last
7 days. Please answer each question even if you do not consider yourself to be an active person.
Please think about the activities you do at work, as part of your house and yard work, to get from
place to place, and in your spare time for recreation, exercise or sport.
Think about all the vigorous and moderate activities that you did in the last 7 days. Vigorous
physical activities refer to activities that take hard physical effort and make you breathe much harder
than normal. Moderate activities refer to activities that take moderate physical effort and make you
breathe somewhat harder than normal.
PART 1: JOB-RELATED PHYSICAL ACTIVITY

The first section is about your work. This includes paid jobs, farming, volunteer work, course work,
and any other unpaid work that you did outside your home. Do not include unpaid work you might
do around your home, like housework, yard work, general maintenance, and caring for your family.
These are asked in Part 3.
1.

Do you currently have a job or do any unpaid work outside your home?
Yes
No

Skip to PART 2: TRANSPORTATION

The next questions are about all the physical activity you did in the last 7 days as part of your paid or
unpaid work. This does not include traveling to and from work.
2.

During the last 7 days, on how many days did you do vigorous physical activities like heavy
lifting, digging, heavy construction, or climbing up stairs as part of your work? Think about
only those physical activities that you did for at least 10 minutes at a time.
_____ days per week
No vigorous job-related physical activity

Skip to question 4

3. How much time did you usually spend on one of those days doing vigorous physical activities as
part of your work?
_____ hours per day
_____ minutes per day
4. Again, think about only those physical activities that you did for at least 10 minutes at a time.
During the last 7 days, on how many days did you do moderate physical activities like carrying
light loads as part of your work? Please do not include walking.
_____ days per week
No moderate job-related physical activity

Skip to question 6

5. How much time did you usually spend on one of those days doing moderate physical activities
as part of your work?
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_____ hours per day
_____ minutes per day
6. During the last 7 days, on how many days did you walk for at least 10 minutes at a time as part
of your work? Please do not count any walking you did to travel to or from work.
_____ days per week
No job-related walking

Skip to PART 2: TRANSPORTATION

7. How much time did you usually spend on one of those days walking as part of your work?
_____
hours per day
_____
minutes per day
PART 2: TRANSPORTATION PHYSICAL ACTIVITY
These questions are about how you traveled from place to place, including to places like work, stores,
movies, and so on.
8. During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus,
car, or tram?
_____ days per week
No traveling in a motor vehicle

Skip to question 10

9. How much time did you usually spend on one of those days traveling in a train, bus, car, tram,
or other kind of motor vehicle?
_____
hours per day
_____
minutes per day
Now think only about the bicycling and walking you might have done to travel to and from work,
to do errands, or to go from place to place.
10. During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go
from place to place?
_____ days per week
No bicycling from place to place

Skip to question 12

11. How much time did you usually spend on one of those days to bicycle from place to place?
_____ hours per day
_____ minutes per day
12. During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go
from place to place?
_____ days per week
No walking from place to place

Skip to PART 3:
HOUSEWORK, HOUSE
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MAINTENANCE, AND
CARING FOR FAMILY
13. How much time did you usually spend on one of those days walking from place to place?
_____ hours per day
_____ minutes per day

PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY

This section is about some of the physical activities you might have done in the last 7 days in and
around your home, like housework, gardening, yard work, general maintenance work, and caring for
your family.
14. Think about only those physical activities that you did for at least 10 minutes at a time. During
the last 7 days, on how many days did you do vigorous physical activities like heavy lifting,
chopping wood, shoveling snow, or digging in the garden or yard?
_____ days per week
No vigorous activity in garden or yard

Skip to question 16

15. How much time did you usually spend on one of those days doing vigorous physical activities in
the garden or yard?
_____ hours per day
_____ minutes per day
16. Again, think about only those physical activities that you did for at least 10 minutes at a time.
During the last 7 days, on how many days did you do moderate activities like carrying light
loads, sweeping, washing windows, and raking in the garden or yard?
_____ days per week
No moderate activity in garden or yard

Skip to question 18

17. How much time did you usually spend on one of those days doing moderate physical activities
in the garden or yard?
_____
hours per day
_____
minutes per day
18. Once again, think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do moderate activities like carrying
light loads, washing windows, scrubbing floors and sweeping inside your home?
_____ days per week
No moderate activity inside home

Skip to PART 4:
RECREATION, SPORT
AND LEISURE-TIME
PHYSICAL ACTIVITY

19. How much time did you usually spend on one of those days doing moderate physical activities
inside your home?
_____ hours per day
_____ minutes per day
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PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY
This section is about all the physical activities that you did in the last 7 days solely for
recreation, sport, exercise or leisure. Please do not include any activities you have already
mentioned.

20. Not counting any walking you have already mentioned, during the last 7 days, on how many
days did you walk for at least 10 minutes at a time in your leisure time?
_____ days per week
No walking in leisure time

Skip to question 22

21. How much time did you usually spend on one of those days walking in your leisure time?
_____ hours per day
_____ minutes per day
22. Think about only those physical activities that you did for at least 10 minutes at a time. During
the last 7 days, on how many days did you do vigorous physical activities like aerobics, running,
fast bicycling, or fast swimming in your leisure time?
_____ days per week
No vigorous activity in leisure time

Skip to question 24

23. How much time did you usually spend on one of those days doing vigorous physical activities in
your leisure time?
_____ hours per day
_____ minutes per day
24. Again, think about only those physical activities that you did for at least 10 minutes at a time.
During the last 7 days, on how many days did you do moderate physical activities like bicycling
at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time?
_____ days per week
No moderate activity in leisure time

Skip to PART 5: TIME
SPENT SITTING

25. How much time did you usually spend on one of those days doing moderate physical activities
in your leisure time?
_____ hours per day
_____
minutes per day

PART 5: TIME SPENT SITTING

The last questions are about the time you spend sitting while at work, at home, while doing
course work and during leisure time. This may include time spent sitting at a desk, visiting
friends, reading or sitting or lying down to watch television. Do not include any time spent
sitting in a motor vehicle that you have already told me about.
26. During the last 7 days, how much time did you usually spend sitting on a weekday?
_____
hours per day
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_____

minutes per day

27. During the last 7 days, how much time did you usually spend sitting on a weekend day?
_____
hours per day
_____
minutes per day
This is the end of the questionnaire, thank you for participating.
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Appendix F: Three Day Food Intake Records
Food Intake Record Directions and Tips:



In the first two columns, note the time and location the food or beverage was consumed.
In the third column, record the food or beverage.


















Be as detailed as possible in describing the food item. For example not just chicken,
but how it was cooked (fried, grilled, baked, etc), and include any sauces or dressings
put on any food item. If you eat a salad, try and write down everything that was in
the salad with appropriate portion sizes. See descriptive words page for words that
you can use.
Include brand names or restaurant names with item names whenever possible.
Examples: Kraft, General Mills, Campbell’s, McDonalds 6 piece McNuggets, etc.
Include toppings such as mustard, ketchup, mayonnaise, cream, sugar, steak sauce,
salsa, dressing, gravy, pickles, honey, butter etc.
If you are at a restaurant, it is more than OK to ask the staff or waiter/waitress how
something was cooked, or about the ingredients in a particular item (ie whether a
dressing is low-fat vs. regular). Additionally, if you want, you can include the
description off the menu.
If you have a recipe or a label of a common food you consume, feel free to bring it
in. The more details you can provide us with, the better!

Determine serving size for food or beverage (columns 4-7):

Portion Size: How many?: How many of this item did you consume?

Portion Size: Food Model: Estimate the size of your food. Options:
o Use the Food Amounts Booklet as a visual guideline.
o OR if you’re cooking at home and you know the measured amount, include
the measurements. You can use household measures such as measuring cups
and spoons to further help you estimate how much you ate.
o OR if a weight from the package is available, include the weight.

Thickness/Ice in drink: If you are using the Food Amounts Booklet, estimate the
thickness of your food. Additionally, this is where you can document drinks with ice.

Reviewers Notes: Leave this column blank.
Please pick two weekdays and one weekend day. The three days should be consecutive
days.
Be as honest as possible! This really helps with the accuracy of the data that is collected.
We are simply trying to document what you consumed over a three day span.
Keep your Food Intake Record and Food Amounts Booklet handy.
You do not need to record while you are eating. We want you to enjoy your meal and
avoid altering what you’re eating. You can wait until the meal is over to start recording.
It is better, however, to record soon after the meal and avoid recording at the end of the
day if possible. This makes it easier to remember what you ate and will likely provide the
research team with a more accurate record.
No need to carry a food scale with you. That’s what the Food Amounts Booklet is for!
Remember to include beverages (even water) and snacks as well.

68
Descriptive words you can include:
1% fat

2 % fat

Air Popped

Au Gratin

Au jus

Au Lait

Buttery

Bisque

Creamy

Canapé

Canned

Chocolate
Covered

Charbroiled

Candied

Candy
Coated

Baked

Broiled

Deep fried

Fire roasted

Fat free

Fire grilled

Honeyed

Lean

Poached

Pan-seared

Golden

Loaded
Seared

Sugared

Grilled

Basted

Breaded

Battered

Deep pan

Drenched

Dressed with

Frozen

Fried

Garden fresh

Gooey

Low sodium

Layered

Lemony

Light

Flamed
broiled

Ground

Low fat

Marinated

Seasoned

Sautéed

Stuffed

Braised

Fresh

Glazed

Fudgy

Hand
battered

Meaty

Melted

Skinny

Stuffed

Reduced Fat

Roasted

Sweet

Toasted

Farci

Homemade

Non Fat

Slow Cooked Smokey

Sugar Coated

Topped With Tossed With

Some information adopted from Nutrition Therapy & Pathophysiology, 2 nd edition, 2011
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Subject ID Number ______________
Page ___ of ___
Day (circle): 1 2 3
Time

Place

Food Description

Date ______________
Food Intake Record

(Please specify, if known: brand names, cooking method, type of
product, and include labels when possible)

Portion
Size : How
many?

Portion
Size : Food
Model

Comments
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Appendix G: Physician Approval Form

Physician Approval Form

Patient Name: ___________________

1. Are there specific concerns or conditions we should be aware of before this individual
engages in the physical fitness assessment for this study??
________________________________________________________________________
______
________________________________________________________________________
______
2. If this individual has completed a graded exercise test (stress test) please provide the
following:
a. Date of Test:
__________________________________________________________
b. A copy of the final exercise report and interpretation.

3. Please provide the following information so that we may contact you if we have any
further questions:
____ I AGREE to the participation of this individual in the herein described study.
____ I DO NOT AGREE that this individual is a candidate for this study.

Physician’s Signature
____________________________________________________
Physician’s name (printed)
____________________________________________________
Address
____________________________________________________
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